WO2020001069A1 - Kit for caring for the skin - Google Patents

Kit for caring for the skin Download PDF

Info

Publication number
WO2020001069A1
WO2020001069A1 PCT/CN2019/078018 CN2019078018W WO2020001069A1 WO 2020001069 A1 WO2020001069 A1 WO 2020001069A1 CN 2019078018 W CN2019078018 W CN 2019078018W WO 2020001069 A1 WO2020001069 A1 WO 2020001069A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
kit
weight
acid
vitamin
Prior art date
Application number
PCT/CN2019/078018
Other languages
French (fr)
Inventor
Liang Zhang
Zoe LEE
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2018/093258 external-priority patent/WO2020000290A1/en
Priority claimed from PCT/CN2018/113992 external-priority patent/WO2020093206A1/en
Application filed by L'oreal filed Critical L'oreal
Priority to CN201980043523.5A priority Critical patent/CN112334124A/en
Publication of WO2020001069A1 publication Critical patent/WO2020001069A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/027Fibers; Fibrils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a cosmetic system, especially to a kit caring for keratin materials, and in particular the skin. Further, the present invention relates to use of same, especially as a mask for caring for keratin materials, especially the skin.
  • compositions for caring for keratin materials in particular the skin
  • masks are known to have high penetration efficacy on the keratin materials.
  • a two-digit market growth of mask cosmetic products in China was seen.
  • paste type a type of masks
  • peel-off type a type of masks
  • gel type a type of tissue
  • wet tissue type a type of masks
  • paste type and peel-off type masks are mainly used for cleansing of the keratin materials
  • gel type and wet tissue type masks are more often used for caring for the skin.
  • water soluble/dispersible active agents in the gel or tissue masks.
  • Some water soluble/dispersible active agents are generally less stable in solvated/dispersed state, e.g., in aqueous solution, compared with the dry form thereof, thus impacting the cosmetic effect thereof.
  • some water soluble vitamins such as ascorbic acid (also known as vitamin C)
  • vitamin C is more readily to be reacted in aqueous solution.
  • vitamin C tends to be hydrolyzed.
  • compositions for caring for the keratin materials to dispense water soluble/dispersible active agents more effectively, in particular for a composition comprising a solvent.
  • compositions for caring for the keratin materials, in particular the skin with an improved easy usage.
  • masks which is capable of texture transformation, for example, from tissue to gel, creating a pleasant consumer experience.
  • masks which have a moisture or actives such as whitening agent delivery capacity that is at least on par with or even greater than that observed with wet tissue type masks.
  • the present inventors discovered that the conception or gist of the present invention is applicable not only to the cosmetic field, but also to other fields like the medical field, then the masks of the preceding aspects may be broadened to kits, which show the benefits described herein in connection with these masks as well.
  • kits I comprising: 1) a first composition in dry form, comprising a substrate comprising at least one water insoluble salt of polyvalent metal and optionally, a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and 2) a second composition comprising at least one aqueous phase, and a) at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion; wherein the first composition and the second composition are separately placed from one another.
  • kits II comprising: 1) a third composition comprising at least one water insoluble substrate; and 2) a fourth composition in dry form, comprising a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
  • kits I and/or 2 for caring for the keratin materials, especially the skin.
  • This use may manifest itself as a process for caring for the keratin materials, especially the skin, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture.
  • kits I and/or 2 for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
  • This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture.
  • the “keratin material” is the skin.
  • skin we intend all the body skin.
  • the keratin material is the face, or the neck, especially the face.
  • topical application it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
  • rinse off it is meant a composition which after being applied on the skin for a predetermined period of time, is removed from the skin by a rinsing composition such as water.
  • alkali metal refers to an element located in Group IA of the periodic table, such as sodium, potassium, lithium or a combination thereof, preferably sodium, potassium or a combination thereof.
  • water-soluble or water-dispersible means a compound which, when introduced into water at 25°C, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution with a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
  • the kit comprises a first composition and a second composition.
  • the kit I comprises a first composition comprising a water insoluble substrate comprising at least one water insoluble salt of polyvalent metal and optionally, a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a second composition, wherein the water soluble/dispersible active agent is distributed uniformly in the substrate.
  • the first composition according to the present invention comprises at least one water insoluble substrate.
  • water insoluble means that the substrate is not dissolvable in water, nor does it break apart upon immersion in water, e.g., having a solubility of less than 0.01g/100g of water or only slightly soluble, e.g., having a solubility of less than 0.5g/100g of water, in water, nor does it break apart in the bulk state upon immersion in water.
  • the substrate may be a woven or nonwoven fabric can comprise, or is made of a fiber of at least one water insoluble salt of polyvalent metal (also referred to as water insoluble polyvalent metal salt fiber hereinafter) , especially an alginate, solely or together with at least one other fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, and synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers, or a mixture thereof. Two or more selected from the other fibers may be used in combination.
  • polyvalent metal also referred to as water insoluble polyvalent metal salt fiber hereinafter
  • the substrate can be made into a wide variety of shapes and forms such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristic of the kit.
  • the substrate is typically designed to fit the area of the skin in the case of mask to which topical application is desired.
  • the substrate is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
  • Non-limiting examples of the substrates useful in the present invention are described, for example, in the patent application WO 02/062132, or EP 2489286A.
  • the water insoluble substrate or the fabric may comprise the water insoluble alginate fiber, especially calcium alginate fiber, in an amount ranging from 10%to 100%by weight, especially from 15%to 50%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  • the water insoluble substrate or the fabric may comprise the at least one other fiber in an amount ranging from 0%to 90%by weight, especially from 50%to 85%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  • a suitable nonwoven fabric made of 20%by weight of calcium alginate fiber and 80%by weight of lyocell fiber, relative to the total weight of the tissue, which is commercially available from the Sanjiang company under the name M762R-40CN.
  • the substrate can comprise at least one water insoluble salt of polyvalent metal.
  • the at least one water insoluble salt of polyvalent metal may be present in form of powder, particulate, fiber or bulk state.
  • the term "particulate" when being used for the water insoluble salt of polyvalent metal, means that the salt is in the form of particles.
  • the first composition of the present invention may comprise the at least one water insoluble salt of polyvalent metal in a content ranging from 20%to 100%by weight, especially from 20%to 50%by weight, relative to the total weight of the first composition.
  • water insoluble salt of polyvalent metal may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof.
  • the useful metal is preferably calcium, copper or a mixture thereof, more preferably calcium.
  • the acid to provide acid anion according to the present invention can be any known acid useful in cosmetic products, provided that the salt formed from the acid with the polyvalent metal is water insoluble or slightly soluble.
  • the typical acids may be used comprise various inorganic acids, e.g., sulphate, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, and various organic acids, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid, as long as the salt formed is water insoluble or slightly soluble.
  • the at least one water insoluble salt of polyvalent metal may be an alginate, preferably chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a mixture thereof, preferably calcium alginate or copper alginate, in particular calcium alginate.
  • alginate in particular means a salt of alginic acid.
  • Alginic acid anatural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
  • Water insoluble alginates in which the principal cation is calcium, are specifically found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus, Fucus spiralis, Ascophyllum nodosum, Macrocystis pyrifera, Alaria esculenta, Eclonia maxima, Lessonia nigrescens, Lessonia trabeculata, Laminaria japonica, Durvillea antarctica, Laminaria hyperborea, Laminaria longicruris, Laminaria digitata, Laminaria saccharina, Laminaria cloustoni, and Saragassum sp.
  • Suitable water insoluble alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
  • the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates” (Carbohydr. Polym., 15, 171-193, 1991) .
  • the first composition of the present invention may comprise the at least one water insoluble alginate in a content ranging from 10%to 100%by weight, especially from 15%to 50%by weight, relative to the total weight of the first composition.
  • the first composition may comprise at least one superabsorbent material.
  • the at least one superabsorbent material may be present in form of powder, particulate, fiber or bulk state.
  • the superabsorbent material advantageously presents very great ability to absorb a liquid, and in particular water. In particular, it may present the capacity to absorb 15 times, or even 20 times to 50 times its own weight in water, e.g. about 25 times to 30 times.
  • the capacity of the superabsorbent material for absorbing liquid can be determined by implementing the following method.
  • M D dry state
  • the superabsorbent material is obtained in the "dry" state by being treated in a drying oven for about 4 hours (h) at about 50°C.
  • Water (or any other liquid that is to be absorbed by the material) is put into contact with the material. This can be done either by immersing the material in the liquid, or else by pouring the liquid onto the material. For example, the material may be immersed for a duration of about 1 minute (min) .
  • the quantity of water (or liquid) is used in excess so as to saturate the material completely, for example.
  • the excess water (or liquid) is then eliminated, e.g. by drip-drying for about 2 min, and the material saturated in liquid is weighed (M L ) .
  • the difference ⁇ between the weight of the material when saturated in liquid and the weight of the material when dry represents the quantity of liquid that it has absorbed, which weight is compared with the dry weight of the material.
  • the resulting value C is indicative of the capacity of the superabsorbent material to absorb the liquid, e.g. expressed in grams of liquid absorbed per gram of dry material:
  • the superabsorbent material may be selected from cellulose derivatives, alginates (not including the water insoluble alginates and the alkali metal alginic compounds described herein) and derivatives thereof, in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
  • alginates not including the water insoluble alginates and the alkali metal alginic compounds described herein
  • derivatives thereof in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
  • the superabsorbent material may be selected from derivatives of chemically modified cellulose.
  • it may be selected from carboxy-methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
  • alkyl celluloses may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modification, e.g. using a carboxylic residue.
  • the superabsorbent material may also be selected from natural polymer derivatives, such as, for example, gelatin and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
  • natural polymer derivatives such as, for example, gelatin and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
  • it may be selected from agar gum, guar gum, gum tragacanth, carrageenan gum, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
  • the first composition of the present invention may comprise the at least one superabsorbent material in a content ranging from 0%to 90%by weight, especially from 50%to 85%by weight, or even the rest in addition to the alignate, relative to the total weight of the first composition.
  • the first composition according to the present invention comprises a water soluble/dispersible active agent, preferably in dry from, still preferably in anhydrous form.
  • An active agent is one capable of bringing cosmetic effect to a user, especially to the skin, e.g., to face.
  • Such cosmetic effect can be, for example, whitening, anti-aging, hydrating, and/or moisturizing.
  • the active agents conventionally useful for a cosmetic product can be used in the second composition according to the present invention, as long as it is water soluble/dispersible.
  • composition of the present invention is particularly applicable to use water soluble/dispersible active agents which are unstable in solvated/dispersed state.
  • unstable we intend to mean an ingredient or composition undergoes significant change in its structure or properties within 2 months, or preferably 1 month, in solvent or solvated/dispersed state. Such change may be any one undesirable for the cosmetic use, including, but not limited to, color change, degradation, decomposition, reaction with others, significant evaporation, deposition, crystallization, and the like.
  • the active agent is selected from the group consisting of retinoids, vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B group (e.g., vitamin B5 (panthenol) , vitamin B3 (niacinamide) , vitamin B1 and vitamin B2) , vitamin D, vitamin K, nicotinic acid, folic acid, pantothenic acid, ferulic acid, ascorbic acid 2-glucoside and dipalmiroyl hydroxyproline, or a derivative thereof, such as a salt or ester thereof.
  • vitamin E tocopherol
  • vitamin C ascorbic acid
  • vitamin B group e.g., vitamin B5 (panthenol)
  • vitamin B3 niacinamide
  • vitamin B1 and vitamin B2 vitamin D
  • vitamin K nicotinic acid
  • folic acid pantothenic acid
  • ferulic acid ascorbic acid 2-glucoside and dipalmiroyl hydroxyproline
  • the water soluble/dispersible active agent is selected from the group consisting of group consisting of retinoids and ferulic acid, wherein the retinoids are retinoic acid, retinol (vitamin A) and its esters, such as, retinyl propionate, and retinyl acetate, or retinyl palmitate.
  • retinoids are retinoic acid, retinol (vitamin A) and its esters, such as, retinyl propionate, and retinyl acetate, or retinyl palmitate.
  • the water soluble/dispersible active agent is retinol or ferulic acid
  • vitamins that are suitable for use in the present invention may be represented, for example, by the products sold under the name ASCORBIC ACID 100 MESH, available from CSPC WEISHENG PHARMACEUTICAL, or from BASF.
  • Useful derivatives of water soluble vitamins comprise preferably 3-o-ethyl ascorbic acid, ascorbyl glucoside, or a mixture thereof.
  • the second composition of the present invention may comprise the at least one water soluble/dispersible active agent in a content ranging from 0.1%to 20%by weight, preferably from 0.5%to 10%by weigh, relative to the total weight of the first composition.
  • the process to form the first composition is not limited specifically, as long as the water soluble/dispersible active agent can be distributed uniformly in the substrate in an amount sufficient to form a gel.
  • the water soluble active agent is prepared into an aqueous solution. Then, the water soluble active agent is loaded onto the substrate, e.g., a mask tissue, through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
  • the substrate e.g., a mask tissue
  • the water soluble/dispersible active agent is prepared into a suspension or paste, e.g., a water soluble/dispersible active agent suspended in or mixed with an aqueous medium other than water to form a suspension or paste thereof. Then, the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble/dispersible active agent in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • a suspension or paste e.g., a water soluble/dispersible active agent suspended in or mixed with an aqueous medium other than water to form a suspension or paste thereof.
  • the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble/dispersible active agent in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • the water dispersible active agent is prepared into an aqueous dispersion, e.g., for water insoluble but dispersible active agent. Then, the dispersion is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water dispersible active agent in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • the wet substrate loaded with the aqueous salt is subsequently dried.
  • the method to dry the tissue is not limited specifically.
  • the wet substrate is dried in an economically effective manner.
  • the water dispersible active agent e.g., as water insoluble salt
  • the water dispersible active agent in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate.
  • the diameter of the powder or particle is not limited specifically, as long as the water dispersible active agent can be distributed uniformly in the substrate in an amount sufficient to form a gel on the substrate, e.g., with alginate.
  • the kit I comprises, in addition to the first composition (e.g. the water insoluble substrate) , a second composition.
  • the second composition after dissolution in aqueous solution, impregnates, coats or is otherwise in contact with the first composition, so as to dispense the active agents from the second composition onto the substrate homogeneously.
  • the weight ratio of the first composition (e.g. the water insoluble substrate or the fabric) to the second composition ranges from 10: 1 to 1: 10, preferably from 5: 1 to 1: 5, or preferably from 2: 1 to 1: 2.
  • the second composition of the present invention at least comprises a) at least one water soluble chelating agent of the polyvalent metal ion and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion.
  • the water insoluble polyvalent metal ion donator reacts with salt in solution and releases the polyvalent metal ions, most of which would be trapped by the water soluble chelating agent.
  • a few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface.
  • the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
  • the second composition according to the present invention comprises at least one water soluble chelating agent of the polyvalent metal ion, to facilitate the texture transformation, and specially, to boost at least the moisture or actives delivery capacity.
  • the water soluble chelating agent of the polyvalent metal ion is water-soluble.
  • the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
  • Both the chelating agent of the polyvalent metal ion and the water soluble gelatinizing agent are capable of being combined with the polyvalent metal ions.
  • the specific chelating agent according to the present invention conquers the gelatinizing agent in the competition of combination with the polyvalent metal ion, such that most of polyvalent metal ions released are trapped by the water soluble chelating agent. There are still a few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. That is, the specific chelating agent according to the present invention serves as a reservoir of the polyvalent metal ions for the gelatinization on the tissue surface.
  • the useful chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, e.g., elhylenediamine tetraacetic acid (EDTA) , aminotriacetic acid, diethylene triaminepentaacetic acid, and in particular the alkali metal salt thereof, e.g., N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic acid diacetic acid, GLDA) ; hydroxyl carboxylic acids, e.g., citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS) , and in particular the alkali metal salt thereof; hydroxyl aminocarboxylic acids, e.g., hydroxyethylethylenediamine triacetic acid (HEDTA) ,
  • EDTA
  • the at least one water soluble chelating agent of the polyvalent metal ion is an alkali metal hydroxyl polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxyl groups (-OH) , preferably by one (1) hydroxyl group, and further substituted by 2, 3, 4 or 5 carboxylate groups (-COOM) , preferably by 2 or 3 carboxylate groups (-COOM) , wherein the multiple groups M independently represent H or alkali metal, with the proviso that at least one of the groups M represents alkali metal, such as Na, K or Li, preferably all groups M represent alkali metal, such as Na, K or Li, preferably Na.
  • alkali metal hydroxyl polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxyl groups (-OH) , preferably
  • the at least one alkali metal hydroxyl polycarboxylate may be chosen from sodium tartrates, sodium citrates, potassium tartrates, potassium citrates, and hydrates thereof, preferably sodium citrates, in particularly trisodium citrate.
  • sodium citrates are used to indicate monosodium citrate, disodium citrate and trisodium citrate, and other alkali metal hydroxyl polycarboxylates may be understood in a similar way.
  • the alkali metal mentioned above is preferably sodium or potassium, in particular sodium.
  • preferable chelating agents can comprise sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or a mixture thereof.
  • the second composition of the present invention may comprise the at least one water soluble chelating agent of the polyvalent metal ion in a content ranging from 0.1%to 1%by weight, especially from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
  • the second composition according to the present invention comprises at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, to trigger the texture transformation.
  • water soluble gelatinizing agent specifically means one gelatinizable with the polyvalent metal ion from the first composition.
  • the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
  • the gelatinizing agent is specifically selected to have an ability of combining with the polyvalent metal ions lower than that of the chelating agent, such that the gelatinizing agent does not combine the free polyvalent metal ions released directly from the first composition, but combines with the polyvalent metal ions subsequently from the reservoir, i.e., the chelated polyvalent metal ions. Accordingly, a gel on the surface of the first composition can be formed.
  • the gelatinizing agent can thus be anyone gelatinizable with the polyvalent metal ion, but has an ability of combining with the polyvalent metal ions lower than that of the chelating agent.
  • the gelatinizing agent can comprise glutins, pectins, gellan gum, carrageenans, agars, alginic compounds and in particular alkali metal salts of alginic acid, e.g., sodium alginate, and mixtures thereof.
  • Pectins are linear polymers of ⁇ -D-galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20%of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose) . L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1, 2.
  • Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO - form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
  • a certain proportion of the carboxylic groups are esterified with a methanol group.
  • the natural degree of esterification of a pectin may range between 70%(apple, lemon) and 10% (strawberry) depending on the source used.
  • pectins with a high degree of esterification it is possible to hydrolyse the-COOCH 3 groups, so as to obtain weakly esterified pectins.
  • the chain is thus more or less acidic.
  • HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%
  • LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
  • the-OCH 3 group is substituted with a-NH 2 group.
  • Pectins are especially sold by the company Cargill under the name Unipectine TM , by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
  • Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by ⁇ (1, 3) and ⁇ (1, 4) bonds. They are highly sulfated polysaccharides (20-50%) and the ⁇ -D-galactopyranosyl residues may be in 3, 6-anhydro form.
  • carrageenans which bear one sulfate-ester group
  • iota-carrageenans which bear two sulfate-ester groups
  • lambda-carrageenans which bear three sulfate-ester groups.
  • Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfate esters.
  • Carrageenans are sold especially by the company SEPPIC under the name by the company Gelymar under the names and by the company Cargill, under the names Satiagel TM and Satiagum TM , and by the company CP-Kelco under the names and
  • Agars are galactose polysaccharides contained in the cell wall of some of these species of red algae (rhodophyceae) . They are formed from a polymer group whose base backbone is a ⁇ (1, 3) D-galactopyranose and ⁇ (1, 4) L 3-6 anhydrogalactose chain, these units repeating regularly and alternately. The differences within the agar family are due to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are generally present in variable percentage, depending on the species of algae and the harvest season.
  • Agar-agar is a mixture of polysaccharides (agarose and agaropectin) of high molecular mass, between 40 000 and 300 000 g. mol -1 . It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2%of agar-agar, so as to extract the latter.
  • Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar) , and Puragar by the company Setexam.
  • Gellan gum is an anionic linear heteropolyoside based on oligoside units composed of 4 saccharides (tetra-oside) .
  • D-Glucose, L-rhamnose and D-glucuronic acid in 2: 1: 1 proportions are present in gellan gum in the form of monomer elements.
  • Kelcogel CG LA It is sold, for example, under the name Kelcogel CG LA by the company CP Kelco.
  • the gelatinizing agent is preferably chosen from alkali metal alginic compounds.
  • the particularly preferable gelatinizing agent is alginate, e.g., sodium or potassium alginate, especially sodium alginate.
  • the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
  • the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
  • alkali metal alginic compound in particular means alkali metal alginic acid salts (alginates) or alkali metal salts of alginic acid derivatives.
  • the alkali metal alginic compound is water-soluble.
  • Alginic acid a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
  • Alginic acid is capable of forming water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water-soluble in aqueous medium at pH 4 but dissociate into alginic acid at a pH below 4.
  • Alginic acid or alginates may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications, forming alginic acid derivatives, including salts.
  • These derivatives may be anionic, cationic, amphoteric or nonionic, and are capable of forming water-soluble salts with an alkali metal such as sodium, potassium or lithium, forming alkali metal salts of alginic acid derivatives.
  • alginates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol alginates.
  • the polyglycol segment is bonded to alginates through the carboxyl group (s) .
  • alginates react with propylene oxide to form polypropylene glycol alginates (PPG alginates)
  • PPG alginates polypropylene glycol alginates
  • PEG alginates polyethylene glycol alginates
  • Preparation of polyglycol alginates is disclosed in Strong, U.S. Pat. No. 3,948,881, Pettitt, U.S. Pat. No. 3,772,266, and Steiner, U.S. Pat. No. 2,426,125.
  • the polyglycol alginate has a degree of esterification of about 40%to about 95%, more preferably about 70%to 95%.
  • Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
  • the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
  • weight-average molecular weights indicated above are also valid for the alkali metal salts of alginic acid derivatives.
  • the alkali metal alginic compound may be chosen from sodium alginate and potassium alginate, preferably sodium alginate.
  • alkali metal alginic compounds that are suitable for use in the present invention may be represented, for example, by the products sold under the names Kelcosol, Satialgine TM , Cecalgum TM or Algogel TM by the company Cargill Products, under the name Protanal TM by the company FMC Biopolymer, under the name Alginate by the company Danisco, under the name Kimica Algin by the company Kimica, and under the names and by the company ISP.
  • the second composition according to the present invention comprises at least one aqueous phase.
  • the at least one aqueous phase comprises water.
  • the aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25°C) , for instance monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols especially containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing from 3 to 16 carbon atoms) such as mono-, di-or tripropylene glycol (C 1 -C 4 ) alkyl ethers, mono-, di-or triethylene glycol (C 1 -C 4 ) alkyl ethers, and mixtures thereof.
  • monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isoprop
  • the aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
  • the second composition of the present invention may comprise the at least one aqueous phase in a content ranging from 10%to 99%by weight, especially from 50%to 99%by weight, and more particularly from 70%to 99%by weight, relative to the total weight of the second composition.
  • the kit II comprises 1) a third composition comprising at least one water insoluble substrate; and 2) a fourth composition in dry form, comprising a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
  • the third composition comprises at least one water insoluble substrate
  • the water insoluble substrate useful for the third composition of the kit II may be same as that for use in the first composition.
  • the water insoluble substrate can be anyone conventionally useful for the cosmetic uses, e.g., for masks.
  • the other components, e.g., superabsorbent material, described above for the first composition can be generally useful for the third composition, as long as the component does not do harm to the effect desired for the kit II. Accordingly, the water soluble/dispersible active agent is not present in the third composition.
  • the fourth composition of the kit II comprises a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
  • the water soluble/dispersible active agent useful for the fourth composition of the kit II may be same as that for use in the first composition.
  • the water insoluble substrate can be anyone conventionally useful for the cosmetic uses, e.g., for masks.
  • a disintegrating agent is used in the fourth composition, for the purpose of facilitating the disintegration of the water soluble/dispersible active agent (s) when it is dissolved in a solvent, e.g., in water. Accordingly, the disintegrating agent is preferably mixed homogenously with the water soluble/dispersible active agent.
  • the disintegrating agent is itself a binder for the active agent, or an additional binder is added, such that the disintegrating agent and the active agent is together formed into integrated solid state, e.g., particles, granules, spheres, beads, balls, bars, strips or the like, in either hollow or solid form.
  • integrated solid state e.g., particles, granules, spheres, beads, balls, bars, strips or the like.
  • the forms of granules, spheres, balls and the like are preferred.
  • the disintegrating agent is preferably selected from the group consisting of starches, e.g., corn starch, tomato starch, or wheat starch; a derivative of starch, e.g., pregelatinized starch, alpha starch, acrylic grafted starch or carboxymethyl starch sodium; saccharide or saccharide alcohol, or mixtures thereof.
  • Saccharide or saccharide alcohol is preferably used as disintegrating agent according to the present invention. More preferably, saccharide or saccharide alcohol serves itself as a binder. Useful saccharides comprise monosaccharide, disaccharide and polysaccharide. The corresponding alcohol of the saccharide may also be useful.
  • saccharides that are suitable for use in the present invention may be represented, for example, by the products sold under the name SUCRE SEMOULE SURFINE 250 from TEREOS.
  • the fourth composition comprising an integrated solid state thereof is preferably produced into particles, preferably in forms of granules, spheres, balls and the like.
  • Process to produce the integrated solid state comprises fluidized bed process, extrusion process, spray process, centrifugal process and others.
  • a fluidized bed process is preferred.
  • the fluidized bed process can be conducted at a temperature from room temperature to an elevated temperature, e.g., about 25 to about 80°C, about 30 to 50°C, e.g., about 35°C.
  • the particles of the integrated solid state of the active agent and disintegrating agent through the steps of:
  • the active agent is provided as particles, e.g., in form of powders, granules, spheres, or balls, for step 1) . If an additional binder is used, it is dissolved together with the disintegrating agent in step 2) .
  • an integrated process of centrifugal-fluidized bed is preferably used, wherein centrifugal force is introduced into the fluidized bed.
  • a vessel storing the active agent is placed in a fluidized bed, and a rotary plate having a diameter slightly less than that of the fluidized bed is installed at the bottom of a fluidized bed, such that a gap is formed between the outer edge of the plate and the inner wall of the fluidized bed, through which gap fluidizing gas is blowing upward.
  • Nozzles are immersed in particles of the active agent.
  • the particles of the active agent sprayed with the disintegrating agent and optionally the bind move to the edge of the plate due to centrifugal force, and is fluidized by the fluidizing gas, during which gravity also applies to the particles.
  • the rotary plate is preferably rotated at a line speed, at the outer edge of the plate, of 100-2000 m/min, preferably 300-1800 m/min, or 500-1500 m/min.
  • the high speed may be lowered, e.g., to 1000-2000 m/min, preferably 1300-1900 m/min; whilst when relatively bigger particles are needed, the high speed may be lowered, e.g., to 100-1000 m/min, preferably 200-700 m/min.
  • the integrated state of the disintegrating agent and the active agent is preferably a particle having a particle size of 20-40 mesh; a max loss of drying of less than 10%, preferably less than 5%, e.g., about 4%; and/or a bulk density between about 500 and 900kg/m 3 .
  • the weight ratio of the disintegrating agent to the active agent in the fourth composition ranges from 1: 100 to 1: 4, preferably from 1: 50 to 1: 5, or preferably from 1: 20 to 1: 10.
  • the fourth composition may comprise cosmetically useful other components, as long as the rapid dissolution of the fourth composition in water is not interfered.
  • a filler with a high solubility in water may be added into the fourth composition.
  • the dissolving speed of the filler is higher than that of the active agent.
  • the fourth composition can comprise a binder additional to and different from the disintegrating agent used, as long as the rapid dissolution of the fourth composition in water is not interfered.
  • the examples of binder can comprise polyvinyl alcohol, sodium alginate, xanthan and agar.
  • kit II comprises the third and fourth compositions.
  • the active agent is kept in dry form, the activity thereof is maintained as high as possible.
  • the third and fourth compositions are separately placed from one another in kit II.
  • the second composition is added into appropriate amount of a solvent, e.g., water, for dissolving the active agent.
  • a solvent e.g., water
  • the active agent is dissolved very rapidly.
  • the solution of the active agent is applied to the water insoluble substrate of the first composition, e.g., through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
  • the first and second compositions are placed in a same package. Immediately before use, the first and second compositions are together added, e.g. immersed, in a solvent, e.g., water.
  • the second composition can be dissolved very rapidly for most cosmetic uses, e.g., within 3 minutes, preferably in 120 seconds, more preferably in 100 seconds.
  • the substrate of the first composition comprises fiber of water insoluble alginate, e.g., calcium alginate.
  • another gelatinizable alginate e.g., sodium alginate
  • agelatinization occurs. Still thanks to the promotion of dissolution of the active agent by the disintegrating agent, dissolution of active agent will be completed rapidly, well before the significant increase of viscosity due to the gelatinization. Accordingly, even for such a gelatinizing system, active agents can still be dispensed onto the substrate.
  • a fifth composition can be further used for the kit II.
  • the fifth composition of the present invention comprises at least one aqueous phase, and at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion. More preferably, the fifth composition comprises: a) . at least one aqueous phase, and b) . at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, and, optionally, c) . at least one water soluble chelating agent of the polyvalent metal ion.
  • the water insoluble polyvalent metal ion donator reacts with the gelatinizing agent in solution and releases the polyvalent metal ions, so as to form a gel.
  • the fifth composition comprises both components b) and c) above
  • the water insoluble polyvalent metal ion donator reacts with the gelatinizing agent in solution and releases the polyvalent metal ions, most of which would be otherwise trapped by the water soluble chelating agent.
  • a few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface.
  • the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
  • the aqueous phase may be same as that described for the second composition of the invention.
  • the gelatinizing agent may be same as that described for the second composition of the invention.
  • the chelating agent may be same as that described for the second composition of the invention.
  • compositions according to the present invention may respectively comprise optionally at least one additional hydrophilic gelling agent.
  • hydrophilic gelling agent means a compound that is capable of gelling the aqueous phase, without combining with the polyvalent metal ions from the first or the third composition.
  • the gelling agent may be water-soluble or water-dispersible.
  • hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents that are natural or of natural origin, or a mixture thereof.
  • the term "synthetic" means that the polymer is neither naturally existing nor a derivative of a polymer of natural origin.
  • the synthetic polymeric gelling agent under consideration according to the present invention may or may not be particulate.
  • the term "particulate" when being used for the synthetic polymeric gelling agent, means that the polymer is in the form of particles, preferably spherical particles.
  • these polymers may be chosen especially from:
  • modified or unmodified carboxyvinyl polymers such as the products sold under the name (CTFA name: Carbomer) by the company Goodrich; polyacrylates, polymethacrylates such as the products sold under the names Lubrajel TM and Norgel by the company Guardian or under the name by the company Hispano Chimica; polyacrylamides; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin (CTFA name: ammonium polyacryldimethyltauramide) ; crosslinked anionic copolymers of acrylamide and of which are in the form of a W/O emulsion, such as those sold under the name Sepigel TM 305 (CTFA name: Polyacrylamide/C 13-14 isoparaffin/Laureth-7) and under the name Simulgel TM 600 (CTFA name: Acryl
  • these polymers may be chosen from Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate copolymer such as SNC, Acrylates copolymer such as Aqua SF-1, Ammonium acryloyldimethyl taurate/steareth-25 Methacrylate Crosspolymer such as HMS, Ammonium acryloyldimethyl taurate such as AVC.
  • Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate cop
  • these polymers may be chosen from carboxyvinyl polymers such as the products (carbomers) such as Ultrez 20 Polymer marketed by Lubrizol and the Pemulen products (acrylate/C 10-30 alkylacrylate copolymer) ; polyacrylamides, for instance the crosslinked copolymers marketed under the trademarks Sepigel TM 305 (CTFA name: polyacrylamide/C 13-14 isoparaffin/Laureth-7) or Simulgel T M 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, which are optionally crosslinked and/or neutralized, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) marketed by Hoechst under the trademark Hostacerin (CTFA name: ammonium polyacryloyldi
  • these polymers may be chosen from glyceryl acrylate/acrylic acid copolymers available from ISP Technologies, Inc. (United Guardian Inc. ) under the tradename Lubrajel TM , particular the form known as Lubrajel TM oil which contains about 1.0%-1.3%glyceryl acrylate/acrylic acid copolymer in aqueous glycerin (about 40%glycerin) .
  • Lubrajel TM oil also includes about 0.6%PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer) .
  • the term "of natural origin” is intended to denote polymeric gelling agents obtained by modification of natural polymeric gelling agents.
  • These gelling agents may be particulate or non-particulate.
  • these gelling agents fall within the category of polysaccharides.
  • polysaccharides that are suitable for use in the present invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose.
  • they may be linear polysaccharides such as pullulan or branched polysaccharides such as gum arabic and amylopectin, or mixed polysaccharides such as starch.
  • the polysaccharides may be chosen from ones produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as gum arables, galactomannans, glucomannans, and derivatives thereof; and mixtures thereof.
  • the polysaccharides may be chosen from fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextrans, celluloses and derivatives thereof, in particular methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans, gum arables, tragacanth gums, ghatti gums, locust bean gums, galactomannans such as guar gums and nonionic derivatives thereof, in particular hydroxypropyl guar, and ionic derivatives thereof, biopoly saccharide gums of microbial origin, in particular
  • polysaccharides may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications.
  • the derivatives obtained may be anionic, cationic, amphoteric or nonionic.
  • the polysaccharides may be chosen from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
  • the compounds of this type that may be used in the present invention are chosen from those described especially in Kirk-Othmer's Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pp. 896-900, and volume 15, pp. 439-458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley&Sons, Chapter 6, pp. 240-328, 1980, in the book by Robert L. Davidson entitled Handbook of Water-Soluble Gums and Resins published by McGraw Hill Book Company (1980) and in Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. Whistler, Second Edition, published by Academic Press Inc.
  • these polysaccharides that are suitable for use in the present invention may be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are detailed below.
  • Xanthan is a heteropolysaccharide produced at the industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of ⁇ (1, 4) -linked ⁇ -D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an ⁇ -D-mannose, a ⁇ -D-glucuronic acid and a terminal ⁇ -D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30%of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6.
  • the charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1) .
  • the content of pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the purification steps. These groups may be neutralized in commercial products with Na + , K + or Ca 2+ ions (Satia company, 1986) .
  • the neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
  • Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa. s for an aqueous composition containing 1%of xanthan gum (measured at 25°C on a Brookfield viscometer of LVT type at 60 rpm) .
  • Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name Satiaxane TM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries) , under the name Novaxan TM by the company ADM, and under the names and by the company CP-Kelco.
  • Pullulan is a polysaccharide consisting of maltotriose units, known under the name ⁇ (1, 4) - ⁇ (1, 6) -glucan. Three glucose units in maltotriose are connected via an ⁇ (1, 4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an ⁇ (1, 6) glycoside bond.
  • Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
  • Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxyl groups. It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
  • Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co.
  • Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
  • Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars) .
  • Succinoglycans are sold, for example, under the name Rheozan by the company Rhodia. Scleroglucan
  • Scleroglucan is a nonionic branched homopolysaccharide consisting of ⁇ -D-glucan units.
  • the molecules consist of a linear main chain formed from D-glucose units linked via ⁇ (1, 3) bonds and of which one in three is linked to a side D-glucose unit via a ⁇ (1, 6) bond.
  • Scleroglucan is sold, for example, under the name Amigel by the company Alban Miiller, or under the name Actigum TM CS by the company Cargill.
  • Furcellaran is obtained commercially from red algae Furcellaria fasztigiata. Furcellaran is produced, for example, by the company Est-Agar.
  • This category of polysaccharides may be divided into homogeneous polysaccharides (only one saccharide species) and heterogeneous polysaccharides composed of several types of saccharides.
  • the polysaccharide according to the present invention may be chosen from celluloses and derivatives or fructosans.
  • the polysaccharide according to the present invention may also be a cellulose or a derivative thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose) .
  • cellulose ethers or esters e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose
  • the present invention may also contain a cellulose-based associative polymer.
  • the repeating unit is the cellobiose dimer.
  • the AGUs are in chair conformation and bear 3 hydroxyl functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6) .
  • the polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre) .
  • the degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
  • the hydroxyl groups of cellulose may react partially or totally with various chemical reagents to give cellulose derivatives having intrinsic properties.
  • the cellulose derivatives may be anionic, cationic, amphoteric or nonionic.
  • cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
  • nonionic cellulose ethers mention may be made of alkylcelluloses such as methylcelluloses and ethylcelluloses; hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses; and mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • alkylcelluloses such as methylcelluloses and ethylcelluloses
  • hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses
  • mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • anionic cellulose ethers mention may be made of carboxyalkylcelluloses and salts thereof.
  • cationic cellulose ethers mention may be made of crosslinked or non-crosslinked, quaternized hydroxyethylcelluloses.
  • the quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine such as laurylamine or stearylamine.
  • a fatty amine such as laurylamine or stearylamine.
  • Another cationic cellulose ether that may be mentioned is hydroxy ethylcellulosehydroxypropyltrimethylammonium.
  • the quaternized cellulose derivatives are, in particular:
  • - quaternized celluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
  • - quaternized hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
  • the alkyl radicals borne by the above quaternized celluloses or hydroxyethylcelluloses preferably contain from 8 to 30 carbon atoms.
  • the aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
  • Examples of quaternized alkylhydroxyethylcelluloses containing C 8-30 fatty chains that may be indicated include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C 12 alkyl) and Quatrisoft LM-X 529-8 (C 18 alkyl) sold by the company Amerchol and the products Crodacel QM, Crodacel QL (C 12 alkyl) and Crodacel QS (C 18 alkyl) sold by the company Croda.
  • - celluloses modified with groups comprising at least one fatty chain for instance hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl groups, especially of C 8-22 , arylalkyl and alkylaryl groups, such as Natrosol Plus Grade 330 CS (C 16 alkyls) sold by the company Aqualon, and
  • polyalkylene glycol alkylphenyl ether groups such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by the company Amerchol.
  • cellulose esters are mineral esters of cellulose (cellulose nitrates, sulfates, phosphates, etc. ) , organic cellulose esters (cellulose monoacetates, triacetates, amidopropionates, acetatebutyrates, acetatepropionates and acetatetrimellitates, etc. ) , and mixed organic/mineral esters of cellulose, such as cellulose acetatebutyrate sulfates and cellulose acetatepropionate sulfates.
  • cellulose ester ethers mention may be made of hydroxypropylmethylcellulose phthalates and ethylcellulose sulfates.
  • the cellulose-based compounds of the present invention may be chosen from unsubstituted celluloses and substituted celluloses.
  • the celluloses and derivatives are represented, for example, by the products sold under the names (microcrystalline cellulose, MCC) by the company FMC Biopolymers, under the name Cekol (carboxymethylcellulose) by the company Noviant (CP-Kelco) , under the name Akucell AF (sodium carboxymethylcellulose) by the company Akzo Nobel, under the name Methocel TM (cellulose ethers ) and Ethocel TM (ethylcellulose) by the company Dow, and under the names (carboxymethylcellulose and sodium carboxymethylcellulose) , (methylcellulose) , Blanose TM (carboxymethylcellulose) , (methylcellulose, hydroxypropylmethylcellulose) , (hydroxypropylcellulose) , (cetylhydroxyethylcellulose) and CS (hydroxy ethylcellulose) by the company Hercules Aqualon.
  • the polysaccharide according to the present invention may especially be a fructosan chosen from inulin and derivatives thereof (especially dicarboxy and carboxymethyl inulins) .
  • Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with several saccharide residues other than fructose.
  • Fructans may be linear or branched.
  • Fructans may be products obtained directly from a plant or microbial source or alternatively products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic.
  • Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60.
  • the first group corresponds to products whose fructose units are for the most part linked via ⁇ (2, 1) bonds. These are essentially linear fructans such as inulins.
  • the second group also corresponds to linear fructoses, but the fructose units are essentially linked via ⁇ (2, 6) bonds. These products are levans.
  • the third group corresponds to mixed fructans, i.e. containing ⁇ (2, 6) and ⁇ (2, 1) sequences. These are essentially branched fructans, such as graminans.
  • the preferred fructans in the compositions according to the present invention are inulins.
  • Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke, preferably from chicory.
  • the polysaccharide especially the inulin, has a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
  • the inulin used for the present invention is represented, for example, by the products sold under the name Beneo TM inulin by the company Orafti, and under the name by the company Sensus.
  • the polysaccharides that may be used according to the present invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, tara gum, acacia gum or gum arabic.
  • Gum arabic is a highly branched acidic polysaccharide which is in the form of mixtures of potassium, magnesium and calcium salts.
  • the monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
  • Galactomannans guar, locust bean, fenugreek, tara gum
  • derivatives guar phosphate, hydroxypropyl guar, etc.
  • Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
  • Galactomannans are macromolecules consisting of a main chain of ⁇ (1, 4) -linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit ⁇ (1, 6) -linked to the main chain.
  • the various galactomannans differ, firstly, by the proportion of ⁇ -D-galactopyranose units present in the polymer, and secondly, by significant differences in terms of distribution of galactose units along the mannose chain.
  • the mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
  • Guar gum is characterized by a mannose/galactose ratio of the order of 2/1.
  • the galactose group is regularly distributed along the mannose chain.
  • guar gums that may be used according to the present invention may be nonionic, cationic or anionic. According to the present invention, use may be made of chemically modified or unmodified nonionic guar gums.
  • the unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name Guar by the company Danisco, under the name Viscogum TM by the company Cargill, and under the name guar gum by the company Aqualon.
  • hydrolysed nonionic guar gums that may be used according to the present invention are represented, for example, by the products sold under the name by the company Danisco.
  • modified nonionic guar gums that may be used according to the present invention are preferably modified with C 1-6 hydroxyalkyl groups, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl groups.
  • nonionic guar gums optionally modified with hydroxyalkyl groups are sold, for example, under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) by the company Rhodia or under the name HP (hydroxypropyl guar) by the company Aqualon.
  • the cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq. /g, more particularly between 0.1 and 1 meq. /g.
  • the charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
  • cationic galactomannan gum means any galactomannan gum containing cationic groups and/or groups that can be ionized into cationic groups.
  • the preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
  • the cationic galactomannan gums used generally have a weight-average molecular mass of between 500 and 5 ⁇ 10 6 approximately and preferably between 10 3 and 3 ⁇ 10 6 approximately.
  • the cationic galactomannan gums that may be used according to the present invention are, for example, gums comprising tri (C 1-4 ) alkylammonium cationic groups. Preferably, 2%to 30%by number of the hydroxyl functions of these gums bear trialkylammonium cationic groups.
  • trialkylammonium groups mention may be made most particularly of trimethylammonium and triethylammonium groups.
  • these groups represent from 5%to 20%by weight relative to the total weight of the modified galactomannan gum.
  • the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyltrimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
  • galactomannan gums in particular guar gums modified with cationic groups are products already known per se and are, for example, described in patents US 3 589 578 and US 4 031 307.
  • Such products are moreover sold especially under the trade names Jaguar EXCEL, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar CI 62 (Guar Hydroxypropyltrimonium Chloride) by the company Rhodia, under the name Guar (Guar Hydroxypropyltrimonium Chloride) by the company Degussa, and under the name 3000 (Guar Hydroxypropyltrimonium Chloride) by the company Aqualon.
  • the anionic guar gums that may be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acid.
  • the anionic group is preferably a carboxylic acid group.
  • the anionic group may also be in the form of an acid salt, especially a sodium, calcium, lithium or potassium salt.
  • anionic guar gums that may be used according to the present invention are preferentially carboxymethyl guar derivatives (carboxymethyl guar or carboxymethyl hydroxypropyl guar) .
  • Locust bean gum is extracted from the seeds of the locust bean tree Ceratonia siliqua) .
  • the unmodified locust bean gum that may be used in the present invention is sold, for example, under the name Viscogum TM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name LBG by the company Danisco.
  • the chemically modified locust bean gums that may be used in the present invention may be represented, for example, by the cationic locust beans sold under the name Catinal CLB (locust bean hydroxypropyltrimonium chloride) by the company Toho.
  • Catinal CLB locust bean hydroxypropyltrimonium chloride
  • the tara gum that may be used in the context of the present invention is sold, for example, under the name Vidogum SP by the company Unipektin.
  • Glucomannan is a polysaccharide of high molecular weight (500 000 ⁇ Mglucomannan ⁇ 2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
  • chitin poly-N-acetyl-D-glucosamine, ⁇ (1, 4) -2-acetamido-2-deoxy-D-glucose
  • chitosan and derivatives chitosan- ⁇ -glycerophosphate, carboxymethylchitin, etc.
  • glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, and preferably hyaluronic acid
  • xylans or arabinoxylans
  • Arabinoxylans are polymers of xylose and arabinose, all grouped under the name pentosans.
  • Xylans consist of a main chain of ⁇ (1, 4) -linked D-xylose units and on which are found three substituents (Rouau&Thibault, 1987) : acid units, ⁇ -L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
  • the polysaccharide is preferably hyaluronic acid, or a salt thereof.
  • the at least one hydrophilic gelling agent may be present in an amount ranging for example from 0.001 to 10%by weight, preferably 0.01 to 5%by weight and more preferably from 0.05 to 3%by weight relative to the total weight of the third composition.
  • the first composition may comprise at least one additional active agent.
  • the second composition may comprise at least one additional active agent.
  • the third composition may comprise at least one additional active agent.
  • the first composition includes the at least one active agent
  • it may be incorporated into the first composition in particular by means of an alternating electric field.
  • the active agent (s) may be incorporated in particular in the powder state.
  • ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
  • ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic
  • anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned ⁇ - and ⁇ -hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin
  • active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
  • active agents for improving the condition of the skin such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
  • enzymes that have activity on the skin such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
  • active agents there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
  • the content of the at least one active agent in the first composition and/or in the third composition may be adjusted as a function of the intended purpose of the kit.
  • Hyaluronic compound may be also used as an active agent according to the present invention.
  • the hyaluronic compound is preferably an alkali metal hyaluronic compound.
  • alkali metal hyaluronic compound in particular means alkali metal salts of hyaluronic acid (hyaluronates) or derivatives thereof.
  • the alkali metal hyaluronic compound is water-soluble.
  • hyaluronic acid or derivatives thereof covers in particular the basic unit of hyaluronic acid of formula:
  • hyaluronic acid comprising a disaccharide dimer, namely D-glucuronic acid and N-acetylglucosamine.
  • hyaluronic acid or derivatives thereof also comprises, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain via alternating ⁇ (1, 4) and ⁇ (1, 3) glycosidic linkages, having a molecular weight (Mw) that can range between 380 and 13 000 000 daltons. This molecular weight depends in large part on the source from which the hyaluronic acid is obtained and/or on the preparation methods.
  • Mw molecular weight
  • hyaluronic acid is present in pericellular gels, in the base substance of the connective tissues of vertebrate organs such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of the joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.
  • hyaluronic acid or derivatives thereof comprises all the fractions or subunits of hyaluronic acid having a molecular weight in particular within the molecular weight range recalled above.
  • the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 50 000 and 5 000 000, in particular between 100 000 and 5 000 000, especially between 400 000 and 5 000 000 Da.
  • the term used is high-molecular-weight hyaluronic acid.
  • the hyaluronic acid fractions that may also be suitable for the use covered by the present invention have a molecular weight of between 50 000 and 400 000 Da.
  • the term used is intermediate-molecular-weight hyaluronic acid.
  • the hyaluronic acid fractions that may be suitable for the use covered by the present invention have a molecular weight of less than 50 000 Da.
  • the term used is low-molecular-weight hyaluronic acid.
  • hyaluronic acid or derivatives thereof also comprises hyaluronic acid esters in particular those in which all or some of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.
  • hyaluronic acid or hyaluronates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates.
  • alkylene oxide such as ethylene oxide or propylene oxide
  • the polyglycol segment is bonded to hyaluronic acid through the carboxyl group (s) .
  • hyaluronic acid or hyaluronates react with propylene oxide to form polypropylene glycol hyaluronates, while react with ethylene oxide to form polyethylene glycol hyaluronates.
  • esters of hyaluronic acid include methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. Such esters have in particular been described in D. Campoccia et al. "Semisynthetic resorbable materials from hyaluronan esterification” , Biomaterials 19 (1998) 2101-2127.
  • the third composition of the present invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
  • adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
  • the third composition according to the present invention may be in various forms, in particular in the form of aqueous solution, dispersion, or emulsion, especially such as a water/oil or oil/water emulsion or multiple emulsions.
  • An emulsion may have an oily or aqueous continuous phase.
  • Such an emulsion may be, for example, an inverse (W/O) emulsion or a direct (O/W) emulsion, or alternatively a multiple emulsion (W/O/W or O/W/O) .
  • the third composition according to the present invention may be in the form of an oil-in-water (O/W) emulsion, water-in-oil (W/O) emulsion, or a multiple emulsion, preferably a oil-in-water (O/W) emulsion.
  • O/W oil-in-water
  • W/O water-in-oil
  • W/W multiple emulsion
  • the third composition of the present invention is preferably an aqueous solution.
  • kit III comprises the third composition comprising a polyvalent metal ion, the fourth composition and the aqueous fifth composition.
  • the active agent is kept in dry form, the activity thereof is maintained as high as possible.
  • the third, fourth and fifth compositions are separately placed from each other in kit III.
  • the fourth composition is added into appropriate amount of the aqueous fifth composition, for dissolving the active agent.
  • the active agent With the promotion by the disintegrating agent, the active agent is dissolved very rapidly.
  • the solution of the active agent is applied to the water insoluble substrate of the third composition, e.g., through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
  • the third and fourth compositions are placed in a same package. Immediately before use, the third and fourth compositions are together added with the aqueous fifth composition. Subsequently, gelatinization between the third and fifth composition, and dissolution of the fourth composition into the fifth composition will concurrently occur. Due to the very rapid dissolution speed of the fourth composition achieved by selecting out the specific disintegrating agent, and optionally the binder, the active agent in the fourth composition, is quickly dissolved into the aqueous phase quite before the completion of gelatinization, such that active agent from the fourth composition is homogeneously distributed in the gel finally formed.
  • the kit III according to the present invention may comprise 1-10%, preferably 2%-5%by weight of a third composition, 0.5-20%, preferably 1-10%, or 2-5%by weight of a fourth composition, and 70-98.5%, preferably 75-95%by weight of a fifth composition, relative to the total weight of the kit III.
  • the kit III presents as a mask comprising:
  • a third composition consisting of a nonwoven fabric (or tissue) comprising from 10%to 100%by weight, preferably from 15%to 50%by weight, of calcium alginate fiber, relative to the total weight of the nonwoven fabric,
  • a fourth composition comprising dry particles of from 20%to 99.9%by weight, preferably from 40%to 95%by weight, especially from 50%to 90%by weight of at least one water soluble/dispersible active agent, and 0.1%to 20%by weight, preferably from 0.2%to 15%by weight, especially from 0.5%to 10%by weight, by weight of at least one disintegrating agent, relative to the total weight of the second composition,
  • a fifth composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of sodium alginate, and from 0.1%to 2%by weight, preferably from 0.2%to 1%by weight, of sodium citrate, relative to the total weight of the third composition,
  • the mask comprises 1-10%, preferably 2-5%by weight of the third composition, 0.5-20%, preferably 1-10%, or 2-5%by weight of the fourth composition, and 70-98.5%, preferably 75-95%by weight of the fifth composition, relative to the total weight of the mask.
  • compositions according to the present invention can be generally prepared according to the general knowledge of a person skilled in the art. Nevertheless, it is to be understood that a person skilled in the art can choose its method of preparation, on the basis of his/her general knowledge, taking into account the nature of the constituents used, for example, their solubility in the vehicle, and the application envisaged for the compositions or the kit.
  • the kit I, II and/or III according to the present invention can be used for conditioning keratin materials, especially the face.
  • This use may manifest itself as a process for conditioning keratin materials, especially the face, comprising the steps of compounding the first composition and the second composition, and optionally the third composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture as a mask.
  • the kit I, II and/or III according to the present invention can be used for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
  • This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the third composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture as a mask or stuffing.
  • compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula.
  • the invention formulas A and B, and comparative formula A were prepared, as the second composition.
  • Protocol of preparation using the second composition in table 1 Putting all the ingredients into beaker, heated to 60°C and homogenized until uniform, cooled down to room temperature.
  • a nonwoven fabric made of solely (100% by weight) of calcium alginate fiber sold by the Sanjiang company under the name M762R-40CN was used.
  • Protocol of preparation using the third composition in table 2 Putting all the ingredients into beaker, heated to 60°C and homogenized until uniform, cooled down to room temperature.
  • first compositions for invention formula C, a nonwoven fabric made of 20%by weight of calcium alginate fiber and 80%by weight of tencel fiber was used; for the invention formula D, a nonwoven fabric made of 100%tencel fiber and treated with calcium stearate was used.
  • Tissue 1.5 gram, 20%by weight calcium alginate comprising 5%by weight of ferulic acid+80%tencel fiber;
  • Protocol of preparation using the first composition in table 1 adding 30g of water in the first composition, stirring until completely dissolved, then mixing with tissue.
  • the present invention and comparative masks were evaluated using the following protocols.
  • Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Perceive the greasiness of skin by moving finger pulp on the face. Then each panelist gave the score from 0 to 15. The less greasiness, the high score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face, and observe the quantity of bubbles around eye, nose and mouth. Then each panelist gave the score from 0 to 15. The less bubbles, the high score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Observe the degree of lines on forehead and nasolabial folds, touch the cheek by index finger and middle figer and perceive the skin softness by tactile way, and observe the degree of fine lines on the cheek. Each panelist gave the score from 0 to 15. The more plumpy skin, the high score was given.
  • Evaluation Index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face for 15 minutes and then take off. Observe the quantity of juice left on skin by visual way. Then each panelist gave the score from 0 to 15. The more juice left on skin, the higher score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Invention A Invention B Comparative A Texture transformation Good Excellent poor Skin adhesion Excellent Excellent fair Fresh feel Excellent Fair good Hydration effect good Excellent fair Moisture delivery capacity excellent Fair poor
  • the mask of the present invention is superior in terms of beneficial properties, e.g. texture transformation, hydration effect and moisture delivery capacity, over the comparative one.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The kit comprises: 1) a first composition comprising at least one water insoluble substrate; and 2) a second composition comprising a water soluble/dispersible active agent and a disintegrating agent in dry form.

Description

KIT FOR CARING FOR THE SKIN TECHNICAL FIELD
The present invention relates to a cosmetic system, especially to a kit caring for keratin materials, and in particular the skin. Further, the present invention relates to use of same, especially as a mask for caring for keratin materials, especially the skin.
BACKGROUND ART
It has always been an ultimate goal of the cosmetic filed to deliver products with skin benefits such as hydration, moisturizing, whitening, cleansing, and so on.
Among all the compositions for caring for keratin materials, in particular the skin, masks are known to have high penetration efficacy on the keratin materials. As a result, for example, a two-digit market growth of mask cosmetic products in China was seen.
In general, there are four types of masks, i.e., paste type, peel-off type, gel type, and wet tissue type. Among which, paste type and peel-off type masks are mainly used for cleansing of the keratin materials, whereas gel type and wet tissue type masks are more often used for caring for the skin. It is known to incorporate water soluble/dispersible active agents in the gel or tissue masks. These masks are claimed to provide high efficiency to the skin, such as hydration, whitening, and so on, thanks to the penetration abilities of the masks.
However, these products are still not satisfying. Some water soluble/dispersible active agents are generally less stable in solvated/dispersed state, e.g., in aqueous solution, compared with the dry form thereof, thus impacting the cosmetic effect thereof. For example, some water soluble vitamins, such as ascorbic acid (also known as vitamin C) , is more readily to be reacted in aqueous solution. In particular, at a lower or higher pH, vitamin C tends to be hydrolyzed.
It is known, in particular in food and pharmaceutical field, to formulate these types of ingredients in dry form, such as beads, granules, particles, tablets, etc.. For example, it is known to produce tablets with ascorbic acid in order to maintain a high amount of active ingredients without degradation. These tablets are then dissolved in the water before application.
However, the inventors found that these products in dry form are still not applicable  in cosmetic field, and in particular in masks products. On one hand, a large amount of water is often required to dissolve completely the products in dry form, on the other, some products are so difficult to dissolve that a long time massaging or external force is required.
Based on the foregoing, there is a need for a new type of composition caring for the keratin materials, in particular the skin, for example cosmetic masks, which integrates two or more of the merits exhibited by the known mask types, but does not suffer from one or more problem (s) associated therewith.
AIMS OF INVENTION
Therefore, in one aspect, it is preferable to provide a composition for caring for the keratin materials to dispense water soluble/dispersible active agents more effectively, in particular for a composition comprising a solvent.
In another aspect, it is preferable to provide a composition for caring for the keratin materials, in particular the skin, with an improved easy usage.
In another aspect, it is preferable to provide masks, which is capable of texture transformation, for example, from tissue to gel, creating a pleasant consumer experience.
In another aspect, it is preferable to provide masks, which have a moisture or actives such as whitening agent delivery capacity that is at least on par with or even greater than that observed with wet tissue type masks.
In another aspect, it is preferable to provide masks, which integrate all of the benefits described in the preceding aspects.
In another aspect, the present inventors discovered that the conception or gist of the present invention is applicable not only to the cosmetic field, but also to other fields like the medical field, then the masks of the preceding aspects may be broadened to kits, which show the benefits described herein in connection with these masks as well.
DISCLOSURE OF INVENTION
One subject of the invention is thus to provide a kit I, comprising: 1) a first composition in dry form, comprising a substrate comprising at least one water insoluble salt of polyvalent metal and optionally, a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and 2) a second composition comprising at least one  aqueous phase, and a) at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion; wherein the first composition and the second composition are separately placed from one another.
Another subject of the present invention is to provide a further kit II comprising: 1) a third composition comprising at least one water insoluble substrate; and 2) a fourth composition in dry form, comprising a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
Another subject of the present invention is use of the kit I and/or 2 according to the present invention for caring for the keratin materials, especially the skin. This use may manifest itself as a process for caring for the keratin materials, especially the skin, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture.
Another subject of the present invention is use of the kit I and/or 2 according to the present invention for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on. This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture.
Other characteristics and advantages of the present invention will emerge more clearly on reading the description and the examples that follow.
DETAILED DESCRIPTION OF INVENTION
Throughout the description, including the claims, the term "comprising a" should be understood as being synonymous with "comprising at least one" , unless otherwise mentioned. Moreover, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
Preferably, the “keratin material” according to the present invention is the skin. By “skin” , we intend all the body skin. Still preferably, the keratin material is the face, or the  neck, especially the face.
By “topical application” , it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
By "rinse off" , it is meant a composition which after being applied on the skin for a predetermined period of time, is removed from the skin by a rinsing composition such as water.
By “alkali metal” , it refers to an element located in Group IA of the periodic table, such as sodium, potassium, lithium or a combination thereof, preferably sodium, potassium or a combination thereof.
The term "water-soluble or water-dispersible" means a compound which, when introduced into water at 25℃, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution with a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
In the application, unless specifically mentioned otherwise, contents, parts and percentages are expressed on a weight basis.
According to the present invention, the kit comprises a first composition and a second composition.
Kit I
The kit I according to the present invention comprises a first composition comprising a water insoluble substrate comprising at least one water insoluble salt of polyvalent metal and optionally, a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a second composition, wherein the water soluble/dispersible active agent is distributed uniformly in the substrate.
First composition
First of all, the first composition according to the present invention comprises at least one water insoluble substrate.
Water insoluble substrate
For the purpose of the present invention, the term “water insoluble” means that the substrate is not dissolvable in water, nor does it break apart upon immersion in water, e.g.,  having a solubility of less than 0.01g/100g of water or only slightly soluble, e.g., having a solubility of less than 0.5g/100g of water, in water, nor does it break apart in the bulk state upon immersion in water..
Typically, the substrate may be a woven or nonwoven fabric can comprise, or is made of a fiber of at least one water insoluble salt of polyvalent metal (also referred to as water insoluble polyvalent metal salt fiber hereinafter) , especially an alginate, solely or together with at least one other fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, and synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers, or a mixture thereof. Two or more selected from the other fibers may be used in combination.
The substrate can be made into a wide variety of shapes and forms such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristic of the kit. Just for example, the substrate is typically designed to fit the area of the skin in the case of mask to which topical application is desired. To this end, when the mask is applied to the face, the substrate is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary. Non-limiting examples of the substrates useful in the present invention are described, for example, in the patent application WO 02/062132, or EP 2489286A.
In particular, the water insoluble substrate or the fabric may comprise the water insoluble alginate fiber, especially calcium alginate fiber, in an amount ranging from 10%to 100%by weight, especially from 15%to 50%by weight, relative to the total weight of the water insoluble substrate or the fabric.
In particular, the water insoluble substrate or the fabric may comprise the at least one other fiber in an amount ranging from 0%to 90%by weight, especially from 50%to 85%by weight, relative to the total weight of the water insoluble substrate or the fabric.
More particularly, a suitable nonwoven fabric made of 20%by weight of calcium alginate fiber and 80%by weight of lyocell fiber, relative to the total weight of the tissue, which is commercially available from the Sanjiang company under the name M762R-40CN.
Water insoluble salt of polyvalent metal
The substrate can comprise at least one water insoluble salt of polyvalent metal.
In particular, the at least one water insoluble salt of polyvalent metal may be present in form of powder, particulate, fiber or bulk state.
For the purposes of the present invention, the term "particulate" , when being used for the water insoluble salt of polyvalent metal, means that the salt is in the form of particles.
According to an embodiment, the first composition of the present invention may comprise the at least one water insoluble salt of polyvalent metal in a content ranging from 20%to 100%by weight, especially from 20%to 50%by weight, relative to the total weight of the first composition.
Specifically, water insoluble salt of polyvalent metal may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof. The useful metal is preferably calcium, copper or a mixture thereof, more preferably calcium.
The acid to provide acid anion according to the present invention can be any known acid useful in cosmetic products, provided that the salt formed from the acid with the polyvalent metal is water insoluble or slightly soluble. The typical acids may be used comprise various inorganic acids, e.g., sulphate, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, and various organic acids, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid, as long as the salt formed is water insoluble or slightly soluble.
More specifically, the at least one water insoluble salt of polyvalent metal may be an alginate, preferably chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a mixture thereof, preferably calcium alginate or copper alginate, in particular calcium alginate.
The term "alginate" in particular means a salt of alginic acid. Alginic acid, anatural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: β-D-mannuronic acid (M) and α-L-glucuronic acid (G) .
Water insoluble alginates, in which the principal cation is calcium, are specifically found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus, Fucus spiralis, Ascophyllum nodosum, Macrocystis pyrifera,  Alaria esculenta, Eclonia maxima, Lessonia nigrescens, Lessonia trabeculata, Laminaria japonica, Durvillea antarctica, Laminaria hyperborea, Laminaria longicruris, Laminaria digitata, Laminaria saccharina, Laminaria cloustoni, and Saragassum sp.
Suitable water insoluble alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons. The weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
According to an embodiment, the first composition of the present invention may comprise the at least one water insoluble alginate in a content ranging from 10%to 100%by weight, especially from 15%to 50%by weight, relative to the total weight of the first composition.
Superabsorbent material
According to an embodiment of the present invention, the first composition may comprise at least one superabsorbent material.
In particular, the at least one superabsorbent material may be present in form of powder, particulate, fiber or bulk state.
The superabsorbent material advantageously presents very great ability to absorb a liquid, and in particular water. In particular, it may present the capacity to absorb 15 times, or even 20 times to 50 times its own weight in water, e.g. about 25 times to 30 times.
The capacity of the superabsorbent material for absorbing liquid can be determined by implementing the following method.
A sample of the superabsorbent material in the powder, fiber, or bulk state, or arranged as a film or a sheet, is weighed while in the dry state (M D) . For example, it is possible to use a non-woven square web having a side of about 1 centimeter (cm) . In the context of the present method, the superabsorbent material is obtained in the "dry" state by being treated in a drying oven for about 4 hours (h) at about 50℃.
Water (or any other liquid that is to be absorbed by the material) is put into contact with the material. This can be done either by immersing the material in the liquid, or else by pouring the liquid onto the material. For example, the material may be immersed for a duration of about 1 minute (min) .
The quantity of water (or liquid) is used in excess so as to saturate the material completely, for example. The excess water (or liquid) is then eliminated, e.g. by drip-drying for about 2 min, and the material saturated in liquid is weighed (M L) .
The difference Δ between the weight of the material when saturated in liquid and the weight of the material when dry represents the quantity of liquid that it has absorbed, which weight is compared with the dry weight of the material. The resulting value C is indicative of the capacity of the superabsorbent material to absorb the liquid, e.g. expressed in grams of liquid absorbed per gram of dry material:
Figure PCTCN2019078018-appb-000001
The superabsorbent material may be selected from cellulose derivatives, alginates (not including the water insoluble alginates and the alkali metal alginic compounds described herein) and derivatives thereof, in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
In particular, the superabsorbent material may be selected from derivatives of chemically modified cellulose. For example, it may be selected from carboxy-methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
It may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modification, e.g. using a carboxylic residue.
The superabsorbent material may also be selected from natural polymer derivatives,  such as, for example, gelatin and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin. For example, it may be selected from agar gum, guar gum, gum tragacanth, carrageenan gum, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
In particular, the first composition of the present invention may comprise the at least one superabsorbent material in a content ranging from 0%to 90%by weight, especially from 50%to 85%by weight, or even the rest in addition to the alignate, relative to the total weight of the first composition.
The first composition according to the present invention comprises a water soluble/dispersible active agent, preferably in dry from, still preferably in anhydrous form.
Water soluble/dispersible active agent
An active agent is one capable of bringing cosmetic effect to a user, especially to the skin, e.g., to face. Such cosmetic effect can be, for example, whitening, anti-aging, hydrating, and/or moisturizing. The active agents conventionally useful for a cosmetic product can be used in the second composition according to the present invention, as long as it is water soluble/dispersible.
For the purpose of the present invention, the composition of the present invention is particularly applicable to use water soluble/dispersible active agents which are unstable in solvated/dispersed state.
For the purpose of the present invention, by “unstable” we intend to mean an ingredient or composition undergoes significant change in its structure or properties within 2 months, or preferably 1 month, in solvent or solvated/dispersed state. Such change may be any one undesirable for the cosmetic use, including, but not limited to, color change, degradation, decomposition, reaction with others, significant evaporation, deposition, crystallization, and the like.
According to one embodiment of the invention, the active agent is selected from the group consisting of retinoids, vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B group (e.g., vitamin B5 (panthenol) , vitamin B3 (niacinamide) , vitamin B1 and vitamin B2) , vitamin D, vitamin K, nicotinic acid, folic acid, pantothenic acid, ferulic acid, ascorbic acid 2-glucoside and dipalmiroyl hydroxyproline, or a derivative thereof, such as a salt or ester  thereof.
Preferably, the water soluble/dispersible active agent is selected from the group consisting of group consisting of retinoids and ferulic acid, wherein the retinoids are retinoic acid, retinol (vitamin A) and its esters, such as, retinyl propionate, and retinyl acetate, or retinyl palmitate.
More preferably, the water soluble/dispersible active agent is retinol or ferulic acid
The vitamins that are suitable for use in the present invention may be represented, for example, by the products sold under the name ASCORBIC ACID 100 MESH, available from CSPC WEISHENG PHARMACEUTICAL, or from BASF.
Useful derivatives of water soluble vitamins comprise preferably 3-o-ethyl ascorbic acid, ascorbyl glucoside, or a mixture thereof.
According to an embodiment, the second composition of the present invention may comprise the at least one water soluble/dispersible active agent in a content ranging from 0.1%to 20%by weight, preferably from 0.5%to 10%by weigh, relative to the total weight of the first composition.
Process to form the first composition
The process to form the first composition is not limited specifically, as long as the water soluble/dispersible active agent can be distributed uniformly in the substrate in an amount sufficient to form a gel.
According to an embodiment, the water soluble active agent is prepared into an aqueous solution. Then, the water soluble active agent is loaded onto the substrate, e.g., a mask tissue, through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
According to another embodiment, the water soluble/dispersible active agent is prepared into a suspension or paste, e.g., a water soluble/dispersible active agent suspended in or mixed with an aqueous medium other than water to form a suspension or paste thereof. Then, the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble/dispersible active agent in the substrate in an amount sufficient to form a gel on the substrate with alginate.
According to another embodiment, the water dispersible active agent is prepared into an aqueous dispersion, e.g., for water insoluble but dispersible active agent. Then, the dispersion is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water dispersible active agent in the substrate in an amount sufficient to form a gel on the substrate with alginate.
For the cases using an aqueous solution, an aqueous dispersion, a suspension or a paste to apply the water soluble/dispersible active agent, the wet substrate loaded with the aqueous salt is subsequently dried. The method to dry the tissue is not limited specifically. For industrial application, the wet substrate is dried in an economically effective manner.
According to still another embodiment, the water dispersible active agent, e.g., as water insoluble salt, in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate. The diameter of the powder or particle is not limited specifically, as long as the water dispersible active agent can be distributed uniformly in the substrate in an amount sufficient to form a gel on the substrate, e.g., with alginate.
The kit I according to the present invention comprises, in addition to the first composition (e.g. the water insoluble substrate) , a second composition. The second composition, after dissolution in aqueous solution, impregnates, coats or is otherwise in contact with the first composition, so as to dispense the active agents from the second composition onto the substrate homogeneously.
Preferably, the weight ratio of the first composition (e.g. the water insoluble substrate or the fabric) to the second composition ranges from 10: 1 to 1: 10, preferably from 5: 1 to 1: 5, or preferably from 2: 1 to 1: 2.
Second Composition
The second composition of the present invention at least comprises a) at least one water soluble chelating agent of the polyvalent metal ion and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion.
According to the present invention, when the first composition is mixed with the second composition, the water insoluble polyvalent metal ion donator reacts with salt in  solution and releases the polyvalent metal ions, most of which would be trapped by the water soluble chelating agent. A few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
Chelating agent of the polyvalent metal ion
The second composition according to the present invention comprises at least one water soluble chelating agent of the polyvalent metal ion, to facilitate the texture transformation, and specially, to boost at least the moisture or actives delivery capacity. The water soluble chelating agent of the polyvalent metal ion is water-soluble.
According to the present invention, when the first composition is mixed with the second composition, the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution. Both the chelating agent of the polyvalent metal ion and the water soluble gelatinizing agent are capable of being combined with the polyvalent metal ions.
Surprisingly, the specific chelating agent according to the present invention conquers the gelatinizing agent in the competition of combination with the polyvalent metal ion, such that most of polyvalent metal ions released are trapped by the water soluble chelating agent. There are still a few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. That is, the specific chelating agent according to the present invention serves as a reservoir of the polyvalent metal ions for the gelatinization on the tissue surface.
According to the present invention, the useful chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, e.g., elhylenediamine tetraacetic acid (EDTA) , aminotriacetic acid, diethylene triaminepentaacetic acid, and in particular the alkali metal salt thereof, e.g., N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA,  tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic acid diacetic acid, GLDA) ; hydroxyl carboxylic acids, e.g., citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS) , and in particular the alkali metal salt thereof; hydroxyl aminocarboxylic acids, e.g., hydroxyethylethylenediamine triacetic acid (HEDTA) , dihydroxyethylglycine (DEG) , and in particular the alkali metal salt thereof; polyphosphonic acid, and in particular the alkali metal salt thereof; other phosphor-containing organic acid, e.g., phytic acid, and in particular the alkali metal salt thereof, e.g., sodium phytate, potassium phytate polycarboxylic acid, e.g., polyacrylic acid, polymethacrylic acid, and in particular the alkali metal salt thereof.
In one embodiment, the at least one water soluble chelating agent of the polyvalent metal ion is an alkali metal hydroxyl polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxyl groups (-OH) , preferably by one (1) hydroxyl group, and further substituted by 2, 3, 4 or 5 carboxylate groups (-COOM) , preferably by 2 or 3 carboxylate groups (-COOM) , wherein the multiple groups M independently represent H or alkali metal, with the proviso that at least one of the groups M represents alkali metal, such as Na, K or Li, preferably all groups M represent alkali metal, such as Na, K or Li, preferably Na. More specifically, the at least one alkali metal hydroxyl polycarboxylate may be chosen from sodium tartrates, sodium citrates, potassium tartrates, potassium citrates, and hydrates thereof, preferably sodium citrates, in particularly trisodium citrate. Herein, sodium citrates are used to indicate monosodium citrate, disodium citrate and trisodium citrate, and other alkali metal hydroxyl polycarboxylates may be understood in a similar way.
Amongst others, the alkali metal mentioned above is preferably sodium or potassium, in particular sodium. Accordingly, preferable chelating agents can comprise sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or a mixture thereof.
In particular, the second composition of the present invention may comprise the at least one water soluble chelating agent of the polyvalent metal ion in a content ranging from 0.1%to 1%by weight, especially from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
Water soluble gelatinizing agent
The second composition according to the present invention comprises at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, to trigger the texture transformation.
In this application, the term "water soluble gelatinizing agent" specifically means one gelatinizable with the polyvalent metal ion from the first composition.
According to the present invention, when the first composition is mixed with the second composition, the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution. The gelatinizing agent is specifically selected to have an ability of combining with the polyvalent metal ions lower than that of the chelating agent, such that the gelatinizing agent does not combine the free polyvalent metal ions released directly from the first composition, but combines with the polyvalent metal ions subsequently from the reservoir, i.e., the chelated polyvalent metal ions. Accordingly, a gel on the surface of the first composition can be formed.
According to principle of the present invention, the gelatinizing agent can thus be anyone gelatinizable with the polyvalent metal ion, but has an ability of combining with the polyvalent metal ions lower than that of the chelating agent. Examples of the gelatinizing agent can comprise glutins, pectins, gellan gum, carrageenans, agars, alginic compounds and in particular alkali metal salts of alginic acid, e.g., sodium alginate, and mixtures thereof.
Pectins are linear polymers of α-D-galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20%of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose) . L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1, 2.
Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO -form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
In the natural state, a certain proportion of the carboxylic groups are esterified with a methanol group. The natural degree of esterification of a pectin may range between 70%(apple, lemon) and 10% (strawberry) depending on the source used. Using pectins  with a high degree of esterification it is possible to hydrolyse the-COOCH 3 groups, so as to obtain weakly esterified pectins. Depending on the proportion of methylated or non-methylated monomers, the chain is thus more or less acidic. HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%, and LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
In the case of amidated pectins, the-OCH 3 group is substituted with a-NH 2 group.
Pectins are especially sold by the company Cargill under the name Unipectine TM, by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by α (1, 3) and β (1, 4) bonds. They are highly sulfated polysaccharides (20-50%) and the α-D-galactopyranosyl residues may be in 3, 6-anhydro form. Depending on the number and position of sulfate-ester groups on the repeating disaccharide of the molecule, several types of carrageenans are distinguished, namely: kappa-carrageenans, which bear one sulfate-ester group, iota-carrageenans, which bear two sulfate-ester groups, and lambda-carrageenans, which bear three sulfate-ester groups.
Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfate esters.
Carrageenans are sold especially by the company SEPPIC under the name 
Figure PCTCN2019078018-appb-000002
by the company Gelymar under the names
Figure PCTCN2019078018-appb-000003
and
Figure PCTCN2019078018-appb-000004
by the company Cargill, under the names Satiagel TM and Satiagum TM, and by the company CP-Kelco under the names
Figure PCTCN2019078018-appb-000005
and
Figure PCTCN2019078018-appb-000006
Agars are galactose polysaccharides contained in the cell wall of some of these species of red algae (rhodophyceae) . They are formed from a polymer group whose base backbone is a β (1, 3) D-galactopyranose and α (1, 4) L 3-6 anhydrogalactose chain, these units repeating regularly and alternately. The differences within the agar family are due to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are generally present in variable percentage, depending on the species of algae  and the harvest season.
Agar-agar is a mixture of polysaccharides (agarose and agaropectin) of high molecular mass, between 40 000 and 300 000 g. mol -1. It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2%of agar-agar, so as to extract the latter.
Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar) , and Puragar by the company Setexam.
Gellan gum is an anionic linear heteropolyoside based on oligoside units composed of 4 saccharides (tetra-oside) . D-Glucose, L-rhamnose and D-glucuronic acid in 2: 1: 1 proportions are present in gellan gum in the form of monomer elements.
It is sold, for example, under the name Kelcogel CG LA by the company CP Kelco.
In one embodiment of the present invention, the gelatinizing agent is preferably chosen from alkali metal alginic compounds. The particularly preferable gelatinizing agent is alginate, e.g., sodium or potassium alginate, especially sodium alginate.
According to an embodiment, the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
According to the present invention, the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
Alkali metal alginic compound
The term "alkali metal alginic compound" in particular means alkali metal alginic acid salts (alginates) or alkali metal salts of alginic acid derivatives. The alkali metal alginic compound is water-soluble.
Alginic acid, a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: β-D-mannuronic acid (M) and α-L-glucuronic acid (G) .
Alginic acid is capable of forming water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water-soluble in aqueous medium at pH 4 but dissociate into alginic acid at a pH below 4.
Methods for the recovery of these water-soluble salts, especially sodium alginate, from natural sources are well known, and are described, for example, in Green, U.S. Pat. No. 2,036,934, and Le Gloahec, U.S. Pat. No. 2,128,551.
Alginic acid or alginates may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications, forming alginic acid derivatives, including salts.
These derivatives may be anionic, cationic, amphoteric or nonionic, and are capable of forming water-soluble salts with an alkali metal such as sodium, potassium or lithium, forming alkali metal salts of alginic acid derivatives.
More specifically, alginates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol alginates. The polyglycol segment is bonded to alginates through the carboxyl group (s) . Typically, alginates react with propylene oxide to form polypropylene glycol alginates (PPG alginates) , while react with ethylene oxide to form polyethylene glycol alginates (PEG alginates) . Preparation of polyglycol alginates is disclosed in Strong, U.S. Pat. No. 3,948,881, Pettitt, U.S. Pat. No. 3,772,266, and Steiner, U.S. Pat. No. 2,426,125.
Preferably, the polyglycol alginate has a degree of esterification of about 40%to about 95%, more preferably about 70%to 95%.
Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons. The weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
The weight-average molecular weights indicated above are also valid for the alkali metal salts of alginic acid derivatives.
A list of various commercially available alginates, their properties, and their sources is found in Shapiro, U.S. Pat. No. 6,334,968, Table 1, column 16, line 49, to column 17, line 18, incorporated herein by reference.
According to an embodiment of the present invention, the alkali metal alginic compound may be chosen from sodium alginate and potassium alginate, preferably sodium alginate.
The alkali metal alginic compounds that are suitable for use in the present invention may be represented, for example, by the products sold under the names Kelcosol, Satialgine TM, Cecalgum TM or Algogel TM by the company Cargill Products, under the name Protanal TM by the company FMC Biopolymer, under the name
Figure PCTCN2019078018-appb-000007
Alginate by the company Danisco, under the name Kimica Algin by the company Kimica, and under the names
Figure PCTCN2019078018-appb-000008
and
Figure PCTCN2019078018-appb-000009
by the company ISP.
Aqueous phase
The second composition according to the present invention comprises at least one aqueous phase.
The at least one aqueous phase comprises water.
The aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25℃) , for instance monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols especially containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing from 3 to 16 carbon atoms) such as mono-, di-or tripropylene glycol (C 1-C 4) alkyl ethers, mono-, di-or triethylene glycol (C 1-C 4) alkyl ethers, and mixtures thereof.
The aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
In particular, the second composition of the present invention may comprise the at least one aqueous phase in a content ranging from 10%to 99%by weight, especially from 50%to 99%by weight, and more particularly from 70%to 99%by weight, relative to the  total weight of the second composition.
Kit II
The kit II according to the present invention comprises 1) a third composition comprising at least one water insoluble substrate; and 2) a fourth composition in dry form, comprising a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
Third composition
The third composition comprises at least one water insoluble substrate
Water insoluble substrate
The water insoluble substrate useful for the third composition of the kit II may be same as that for use in the first composition. Or alternatively, the water insoluble substrate can be anyone conventionally useful for the cosmetic uses, e.g., for masks.
The other components, e.g., superabsorbent material, described above for the first composition can be generally useful for the third composition, as long as the component does not do harm to the effect desired for the kit II. Accordingly, the water soluble/dispersible active agent is not present in the third composition.
Fourth composition
The fourth composition of the kit II comprises a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
Water soluble/dispersible active agent
The water soluble/dispersible active agent useful for the fourth composition of the kit II may be same as that for use in the first composition. Or alternatively, the water insoluble substrate can be anyone conventionally useful for the cosmetic uses, e.g., for masks.
Disintegrating agent
A disintegrating agent is used in the fourth composition, for the purpose of facilitating the disintegration of the water soluble/dispersible active agent (s) when it is dissolved in a solvent, e.g., in water. Accordingly, the disintegrating agent is preferably mixed homogenously with the water soluble/dispersible active agent.
As the active agent and the disintegrating agent are both present in a dry form in the fourth composition, in order to keep homogeneous mixed state, it is preferable that the disintegrating agent is itself a binder for the active agent, or an additional binder is added, such that the disintegrating agent and the active agent is together formed into integrated solid state, e.g., particles, granules, spheres, beads, balls, bars, strips or the like, in either hollow or solid form. For rapid and unitary disintegration and dissolution of the active agent, the forms of granules, spheres, balls and the like are preferred.
Accordingly, the disintegrating agent is preferably selected from the group consisting of starches, e.g., corn starch, tomato starch, or wheat starch; a derivative of starch, e.g., pregelatinized starch, alpha starch, acrylic grafted starch or carboxymethyl starch sodium; saccharide or saccharide alcohol, or mixtures thereof.
Saccharide and saccharide alcohol
Saccharide or saccharide alcohol is preferably used as disintegrating agent according to the present invention. More preferably, saccharide or saccharide alcohol serves itself as a binder. Useful saccharides comprise monosaccharide, disaccharide and polysaccharide. The corresponding alcohol of the saccharide may also be useful.
Amongst the monosaccharide, preference may be made to glucose and fructose. Amongst the disaccharide, preference may be made to sucrose. Amongst the saccharide alcohol, preference may be made to sorbitol and mannitol.
The saccharides that are suitable for use in the present invention may be represented, for example, by the products sold under the name SUCRE SEMOULE SURFINE 250 from TEREOS.
Formation of the fourth composition
For rapidly dissolving the disintegrating agent with the active agent, the fourth composition comprising an integrated solid state thereof is preferably produced into particles, preferably in forms of granules, spheres, balls and the like. Process to produce the integrated solid state comprises fluidized bed process, extrusion process, spray process, centrifugal process and others. A fluidized bed process is preferred. The  fluidized bed process can be conducted at a temperature from room temperature to an elevated temperature, e.g., about 25 to about 80℃, about 30 to 50℃, e.g., about 35℃.
For the fluidized bed process, it is preferably to prepare the particles of the integrated solid state of the active agent and disintegrating agent through the steps of:
1) . Providing the active agent in solid;
2) . Dissolving the disintegrating agent into water; and
3) . Feeding the active agent and the aqueous solution of the disintegrating agent into a fluidized bed to produce particles.
Preferably, the active agent is provided as particles, e.g., in form of powders, granules, spheres, or balls, for step 1) . If an additional binder is used, it is dissolved together with the disintegrating agent in step 2) .
For high availability of the aqueous solution and homogeneity of the particles of the integrated solid stage, an integrated process of centrifugal-fluidized bed is preferably used, wherein centrifugal force is introduced into the fluidized bed. According to this integrated process, a vessel storing the active agent is placed in a fluidized bed, and a rotary plate having a diameter slightly less than that of the fluidized bed is installed at the bottom of a fluidized bed, such that a gap is formed between the outer edge of the plate and the inner wall of the fluidized bed, through which gap fluidizing gas is blowing upward. Nozzles are immersed in particles of the active agent. The particles of the active agent sprayed with the disintegrating agent and optionally the bind move to the edge of the plate due to centrifugal force, and is fluidized by the fluidizing gas, during which gravity also applies to the particles.
The rotary plate is preferably rotated at a line speed, at the outer edge of the plate, of 100-2000 m/min, preferably 300-1800 m/min, or 500-1500 m/min. When relatively bigger particles are needed, the high speed may be lowered, e.g., to 1000-2000 m/min, preferably 1300-1900 m/min; whilst when relatively bigger particles are needed, the high speed may be lowered, e.g., to 100-1000 m/min, preferably 200-700 m/min.
The integrated state of the disintegrating agent and the active agent is preferably a particle having a particle size of 20-40 mesh; a max loss of drying of less than 10%, preferably less than 5%, e.g., about 4%; and/or a bulk density between about 500 and 900kg/m 3.
For the purpose of the invention, the weight ratio of the disintegrating agent to the  active agent in the fourth composition ranges from 1: 100 to 1: 4, preferably from 1: 50 to 1: 5, or preferably from 1: 20 to 1: 10.
Optionally other components
The fourth composition may comprise cosmetically useful other components, as long as the rapid dissolution of the fourth composition in water is not interfered. For example, a filler with a high solubility in water may be added into the fourth composition. Preferably, the dissolving speed of the filler is higher than that of the active agent. In particular, the fourth composition can comprise a binder additional to and different from the disintegrating agent used, as long as the rapid dissolution of the fourth composition in water is not interfered. The examples of binder can comprise polyvinyl alcohol, sodium alginate, xanthan and agar.
Use and Form of Kit II
According to the present invention, kit II comprises the third and fourth compositions. As the active agent is kept in dry form, the activity thereof is maintained as high as possible.
In an embodiment of the present invention, the third and fourth compositions are separately placed from one another in kit II. Immediately before use, the second composition is added into appropriate amount of a solvent, e.g., water, for dissolving the active agent. With the promotion by the disintegrating agent, the active agent is dissolved very rapidly. Then, the solution of the active agent is applied to the water insoluble substrate of the first composition, e.g., through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
In another embodiment of the present invention, thanks to the promotion of dissolution of the active agent by the disintegrating agent, the first and second compositions are placed in a same package. Immediately before use, the first and second compositions are together added, e.g. immersed, in a solvent, e.g., water.
For cosmetic use, in many circumstances, water cannot be added in an extremely excessive amount, while a very rapid dissolving speed of the second composition is highly desired, to satisfy, e.g., the demand by uses to substantially instant use of a fresh-mixing product, e.g., a fresh mix mask. Due to the specific selections on both the  active agent and the disintegrating agent, and optionally the binder, the second composition can be dissolved very rapidly for most cosmetic uses, e.g., within 3 minutes, preferably in 120 seconds, more preferably in 100 seconds.
In another embodiment of the present invention, the substrate of the first composition comprises fiber of water insoluble alginate, e.g., calcium alginate. When such a substrate is applied with another gelatinizable alginate, e.g., sodium alginate, agelatinization occurs. Still thanks to the promotion of dissolution of the active agent by the disintegrating agent, dissolution of active agent will be completed rapidly, well before the significant increase of viscosity due to the gelatinization. Accordingly, even for such a gelatinizing system, active agents can still be dispensed onto the substrate.
Fifth composition
For a product where the third composition according to the present invention comprises a polyvalent metal ion, a fifth composition can be further used for the kit II. The fifth composition of the present invention comprises at least one aqueous phase, and at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion. More preferably, the fifth composition comprises: a) . at least one aqueous phase, and b) . at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, and, optionally, c) . at least one water soluble chelating agent of the polyvalent metal ion.
According to the present invention, when the first composition is mixed with the fifth composition, the water insoluble polyvalent metal ion donator reacts with the gelatinizing agent in solution and releases the polyvalent metal ions, so as to form a gel.
In the case that the fifth composition comprises both components b) and c) above, when the first composition is mixed with the fifth composition, the water insoluble polyvalent metal ion donator reacts with the gelatinizing agent in solution and releases the polyvalent metal ions, most of which would be otherwise trapped by the water soluble chelating agent. A few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a  short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
According to an embodiment of the invention, the aqueous phase may be same as that described for the second composition of the invention.
According to an embodiment of the invention, the gelatinizing agent may be same as that described for the second composition of the invention.
According to an embodiment of the invention, the chelating agent may be same as that described for the second composition of the invention.
Other components described above for the second composition can be generally useful for the fifth composition, as long as the component does not do harm to the effect desired for the kit II.
Hydrophilic gelling agent
The second and fifth compositions according to the present invention may respectively comprise optionally at least one additional hydrophilic gelling agent.
For the purposes of the present invention, the term "hydrophilic gelling agent" means a compound that is capable of gelling the aqueous phase, without combining with the polyvalent metal ions from the first or the third composition.
The gelling agent may be water-soluble or water-dispersible.
More specifically, the hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents that are natural or of natural origin, or a mixture thereof.
Synthetic polymeric gelling agents
For the purposes of the present invention, the term "synthetic" means that the polymer is neither naturally existing nor a derivative of a polymer of natural origin.
The synthetic polymeric gelling agent under consideration according to the present invention may or may not be particulate.
For the purposes of the present invention, the term "particulate" , when being used for the synthetic polymeric gelling agent, means that the polymer is in the form of particles, preferably spherical particles.
More specifically, these polymers may be chosen especially from:
modified or unmodified carboxyvinyl polymers, such as the products sold under the  name
Figure PCTCN2019078018-appb-000010
 (CTFA name: Carbomer) by the company Goodrich; polyacrylates, polymethacrylates such as the products sold under the names Lubrajel TM and Norgel by the company Guardian or under the name
Figure PCTCN2019078018-appb-000011
by the company Hispano Chimica; polyacrylamides; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin
Figure PCTCN2019078018-appb-000012
 (CTFA name: ammonium polyacryldimethyltauramide) ; crosslinked anionic copolymers of acrylamide and of
Figure PCTCN2019078018-appb-000013
which are in the form of a W/O emulsion, such as those sold under the name Sepigel TM 305 (CTFA name: Polyacrylamide/C 13-14 isoparaffin/Laureth-7) and under the name Simulgel TM 600 (CTFA name: Acrylamide/Sodium acryloyldimethyltaurate copolymer/Isohexadecane/Polysorbate 80) by the company SEPPIC; and mixtures thereof.
Preferably, these polymers may be chosen from Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, 
Figure PCTCN2019078018-appb-000014
ultrez 20, 
Figure PCTCN2019078018-appb-000015
ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 
Figure PCTCN2019078018-appb-000016
1382, 
Figure PCTCN2019078018-appb-000017
ETD 2020, Carbomer such as
Figure PCTCN2019078018-appb-000018
K, 
Figure PCTCN2019078018-appb-000019
980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate copolymer such as
Figure PCTCN2019078018-appb-000020
SNC, Acrylates copolymer such as
Figure PCTCN2019078018-appb-000021
Aqua SF-1, Ammonium acryloyldimethyl taurate/steareth-25 Methacrylate Crosspolymer such as 
Figure PCTCN2019078018-appb-000022
HMS, Ammonium acryloyldimethyl taurate such as
Figure PCTCN2019078018-appb-000023
AVC.
Preferably, these polymers may be chosen from carboxyvinyl polymers such as the 
Figure PCTCN2019078018-appb-000024
products (carbomers) such as
Figure PCTCN2019078018-appb-000025
Ultrez 20 Polymer marketed by Lubrizol and the Pemulen products (acrylate/C 10-30 alkylacrylate copolymer) ; polyacrylamides, for instance the crosslinked copolymers marketed under the trademarks Sepigel TM 305 (CTFA name: polyacrylamide/C 13-14 isoparaffin/Laureth-7) or Simulgel T M 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, which are optionally crosslinked and/or neutralized, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) marketed by Hoechst under the trademark Hostacerin
Figure PCTCN2019078018-appb-000026
 (CTFA name: ammonium polyacryloyldimethyltaurate) or Simulgel TM 800 marketed by SEPPIC (CTFA name: sodium polyacryloyldimethyltaurate/polysorbate 80/sorbitan oleate) ; copolymers of  2-acrylamido-2-methylpropanesulfonic acid and of hydroxyethyl acrylate, for instance Simulgel TM NS and Sepinov EMT 10 marketed by SEPPIC; and mixtures thereof.
Preferably, these polymers may be chosen from glyceryl acrylate/acrylic acid copolymers available from ISP Technologies, Inc. (United Guardian Inc. ) under the tradename Lubrajel TM, particular the form known as Lubrajel TM oil which contains about 1.0%-1.3%glyceryl acrylate/acrylic acid copolymer in aqueous glycerin (about 40%glycerin) . Lubrajel TM oil also includes about 0.6%PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer) .
Polymeric gelling agents that are natural or of natural origin
For the purposes of the present invention, the term "of natural origin" is intended to denote polymeric gelling agents obtained by modification of natural polymeric gelling agents.
These gelling agents may be particulate or non-particulate.
More specifically, these gelling agents fall within the category of polysaccharides.
In general, polysaccharides that are suitable for use in the present invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose.
Similarly, they may be linear polysaccharides such as pullulan or branched polysaccharides such as gum arabic and amylopectin, or mixed polysaccharides such as starch.
In general, the polysaccharides may be chosen from ones produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as gum arables, galactomannans, glucomannans, and derivatives thereof; and mixtures thereof.
In particular, the polysaccharides may be chosen from fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextrans, celluloses and derivatives thereof, in particular methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans, gum arables, tragacanth gums, ghatti gums, locust bean gums, galactomannans such as guar gums and nonionic derivatives thereof, in  particular hydroxypropyl guar, and ionic derivatives thereof, biopoly saccharide gums of microbial origin, in particular scleroglucan or xanthan gums, mucopolysaccharides, and in particular chondroitin sulfates, and mixtures thereof. These polysaccharides may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications.
The derivatives obtained may be anionic, cationic, amphoteric or nonionic.
Advantageously, the polysaccharides may be chosen from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
In general, the compounds of this type that may be used in the present invention are chosen from those described especially in Kirk-Othmer's Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pp. 896-900, and volume 15, pp. 439-458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley&Sons, Chapter 6, pp. 240-328, 1980, in the book by Robert L. Davidson entitled Handbook of Water-Soluble Gums and Resins published by McGraw Hill Book Company (1980) and in Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. Whistler, Second Edition, published by Academic Press Inc.
More precisely, these polysaccharides that are suitable for use in the present invention may be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are detailed below.
Polysaccharides produced by microorganisms
Xanthan
Xanthan is a heteropolysaccharide produced at the industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of β (1, 4) -linked β-D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an α-D-mannose, a β-D-glucuronic acid and a terminal β-D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30%of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6. The charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1) . The content of pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the  purification steps. These groups may be neutralized in commercial products with Na +, K + or Ca 2+ions (Satia company, 1986) . The neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa. s for an aqueous composition containing 1%of xanthan gum (measured at 25℃ on a Brookfield viscometer of LVT type at 60 rpm) .
Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name Satiaxane TM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries) , under the name Novaxan TM by the company ADM, and under the names
Figure PCTCN2019078018-appb-000027
and 
Figure PCTCN2019078018-appb-000028
by the company CP-Kelco.
Pullulan
Pullulan is a polysaccharide consisting of maltotriose units, known under the name α (1, 4) -α (1, 6) -glucan. Three glucose units in maltotriose are connected via an α (1, 4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an α (1, 6) glycoside bond.
Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
Dextran and dextran sulfate
Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxyl groups. It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co. Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
Succinoglycan
Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars) . Succinoglycans are sold, for example, under the name Rheozan by the company  Rhodia. Scleroglucan
Scleroglucan is a nonionic branched homopolysaccharide consisting of β-D-glucan units. The molecules consist of a linear main chain formed from D-glucose units linked via β (1, 3) bonds and of which one in three is linked to a side D-glucose unit via a β (1, 6) bond.
A more complete description of scleroglucans and of their preparation may be found in patent US 3 301 848.
Scleroglucan is sold, for example, under the name Amigel by the company Alban Miiller, or under the name Actigum TM CS by the company Cargill.
Polysaccharides isolated from algae
Furcellaran
Furcellaran is obtained commercially from red algae Furcellaria fasztigiata. Furcellaran is produced, for example, by the company Est-Agar.
Polysaccharides of higher plants
This category of polysaccharides may be divided into homogeneous polysaccharides (only one saccharide species) and heterogeneous polysaccharides composed of several types of saccharides.
a) Homogeneous polysaccharides and derivatives thereof
The polysaccharide according to the present invention may be chosen from celluloses and derivatives or fructosans.
Cellulose and derivatives
The polysaccharide according to the present invention may also be a cellulose or a derivative thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose) .
The present invention may also contain a cellulose-based associative polymer.
According to the present invention, the term "cellulose-based compound'means any polysaccharide compound bearing in its structure linear sequences of anhydroglucopyranose residues (AGU) linked together via β (1, 4) bonds. The repeating unit is the cellobiose dimer. The AGUs are in chair conformation and bear 3 hydroxyl functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6) .  The polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre) .
The degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
The hydroxyl groups of cellulose may react partially or totally with various chemical reagents to give cellulose derivatives having intrinsic properties. The cellulose derivatives may be anionic, cationic, amphoteric or nonionic. Among these derivatives, cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
Among the nonionic cellulose ethers, mention may be made of alkylcelluloses such as methylcelluloses and ethylcelluloses; hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses; and mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
Among the anionic cellulose ethers, mention may be made of carboxyalkylcelluloses and salts thereof. By way of example, mention may be made of carboxymethylcelluloses, carboxymethylmethylcelluloses and carboxymethylhydroxy-ethylcelluloses and sodium salts thereof.
Among the cationic cellulose ethers, mention may be made of crosslinked or non-crosslinked, quaternized hydroxyethylcelluloses.
The quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine such as laurylamine or stearylamine. Another cationic cellulose ether that may be mentioned is hydroxy ethylcellulosehydroxypropyltrimethylammonium.
The quaternized cellulose derivatives are, in particular:
- quaternized celluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
- quaternized hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
The alkyl radicals borne by the above quaternized celluloses or hydroxyethylcelluloses preferably contain from 8 to 30 carbon atoms. The aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
Examples of quaternized alkylhydroxyethylcelluloses containing C 8-30 fatty chains that may be indicated include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C 12 alkyl) and Quatrisoft LM-X 529-8 (C 18 alkyl) sold by the company Amerchol and the products Crodacel QM, Crodacel QL (C 12 alkyl) and Crodacel QS (C 18 alkyl) sold by the company Croda.
Among the cellulose derivatives, mention may also be made of:
- celluloses modified with groups comprising at least one fatty chain, for instance hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl groups, especially of C 8-22, arylalkyl and alkylaryl groups, such as Natrosol Plus Grade 330 CS (C 16 alkyls) sold by the company Aqualon, and
- celluloses modified with polyalkylene glycol alkylphenyl ether groups, such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by the company Amerchol.
Among the cellulose esters are mineral esters of cellulose (cellulose nitrates, sulfates, phosphates, etc. ) , organic cellulose esters (cellulose monoacetates, triacetates, amidopropionates, acetatebutyrates, acetatepropionates and acetatetrimellitates, etc. ) , and mixed organic/mineral esters of cellulose, such as cellulose acetatebutyrate sulfates and cellulose acetatepropionate sulfates. Among the cellulose ester ethers, mention may be made of hydroxypropylmethylcellulose phthalates and ethylcellulose sulfates.
The cellulose-based compounds of the present invention may be chosen from unsubstituted celluloses and substituted celluloses. The celluloses and derivatives are represented, for example, by the products sold under the names
Figure PCTCN2019078018-appb-000029
 (microcrystalline cellulose, MCC) by the company FMC Biopolymers, under the name Cekol (carboxymethylcellulose) by the company Noviant (CP-Kelco) , under the name Akucell AF (sodium carboxymethylcellulose) by the company Akzo Nobel, under the name Methocel TM (cellulose ethers ) and Ethocel TM (ethylcellulose) by the company Dow, and under the names
Figure PCTCN2019078018-appb-000030
 (carboxymethylcellulose and sodium carboxymethylcellulose) , 
Figure PCTCN2019078018-appb-000031
(methylcellulose) , Blanose TM (carboxymethylcellulose) , 
Figure PCTCN2019078018-appb-000032
(methylcellulose, hydroxypropylmethylcellulose) , 
Figure PCTCN2019078018-appb-000033
 (hydroxypropylcellulose) , 
Figure PCTCN2019078018-appb-000034
(cetylhydroxyethylcellulose) and
Figure PCTCN2019078018-appb-000035
CS (hydroxy ethylcellulose) by the company Hercules Aqualon.
Fructosans
The polysaccharide according to the present invention may especially be a fructosan chosen from inulin and derivatives thereof (especially dicarboxy and carboxymethyl inulins) .
Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with several saccharide residues other than fructose. Fructans may be linear or branched. Fructans may be products obtained directly from a plant or microbial source or alternatively products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic. Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60.
Three groups of fructans are distinguished. The first group corresponds to products whose fructose units are for the most part linked via β (2, 1) bonds. These are essentially linear fructans such as inulins.
The second group also corresponds to linear fructoses, but the fructose units are essentially linked via β (2, 6) bonds. These products are levans.
The third group corresponds to mixed fructans, i.e. containing β (2, 6) and β (2, 1) sequences. These are essentially branched fructans, such as graminans.
The preferred fructans in the compositions according to the present invention are inulins. Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke, preferably from chicory.
In particular, the polysaccharide, especially the inulin, has a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
The inulin used for the present invention is represented, for example, by the products sold under the name Beneo TM inulin by the company Orafti, and under the name 
Figure PCTCN2019078018-appb-000036
by the company Sensus.
b) Heterogeneous polysaccharides and derivatives thereof
The polysaccharides that may be used according to the present invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, tara gum, acacia gum or gum arabic.
Gum arabic
Gum arabic is a highly branched acidic polysaccharide which is in the form of  mixtures of potassium, magnesium and calcium salts. The monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
Galactomannans (guar, locust bean, fenugreek, tara gum) and derivatives (guar phosphate, hydroxypropyl guar, etc. )
Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
Galactomannans are macromolecules consisting of a main chain of β (1, 4) -linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit α (1, 6) -linked to the main chain. The various galactomannans differ, firstly, by the proportion of α-D-galactopyranose units present in the polymer, and secondly, by significant differences in terms of distribution of galactose units along the mannose chain.
The mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
Guar
Guar gum is characterized by a mannose/galactose ratio of the order of 2/1. The galactose group is regularly distributed along the mannose chain.
The guar gums that may be used according to the present invention may be nonionic, cationic or anionic. According to the present invention, use may be made of chemically modified or unmodified nonionic guar gums.
The unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name
Figure PCTCN2019078018-appb-000037
Guar by the company Danisco, under the name Viscogum TM by the company Cargill, and under the name 
Figure PCTCN2019078018-appb-000038
guar gum by the company Aqualon.
The hydrolysed nonionic guar gums that may be used according to the present invention are represented, for example, by the products sold under the name
Figure PCTCN2019078018-appb-000039
by the company Danisco.
The modified nonionic guar gums that may be used according to the present invention are preferably modified with C 1-6 hydroxyalkyl groups, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl groups.
Such nonionic guar gums optionally modified with hydroxyalkyl groups are sold,  for example, under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) by the company Rhodia or under the name
Figure PCTCN2019078018-appb-000040
HP (hydroxypropyl guar) by the company Aqualon.
The cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq. /g, more particularly between 0.1 and 1 meq. /g. The charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
In general, for the purposes of the present invention, the term "cationic galactomannan gum" means any galactomannan gum containing cationic groups and/or groups that can be ionized into cationic groups.
The preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
The cationic galactomannan gums used generally have a weight-average molecular mass of between 500 and 5×10 6 approximately and preferably between 10 3 and 3×10 6 approximately.
The cationic galactomannan gums that may be used according to the present invention are, for example, gums comprising tri (C 1-4) alkylammonium cationic groups. Preferably, 2%to 30%by number of the hydroxyl functions of these gums bear trialkylammonium cationic groups.
Among these trialkylammonium groups, mention may be made most particularly of trimethylammonium and triethylammonium groups.
Even more preferentially, these groups represent from 5%to 20%by weight relative to the total weight of the modified galactomannan gum.
According to the present invention, the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyltrimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
These galactomannan gums, in particular guar gums modified with cationic groups are products already known per se and are, for example, described in patents US 3 589 578 and US 4 031 307. Such products are moreover sold especially under the trade names Jaguar EXCEL, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar CI 62 (Guar Hydroxypropyltrimonium Chloride) by the company Rhodia, under the name
Figure PCTCN2019078018-appb-000041
Guar (Guar Hydroxypropyltrimonium Chloride) by the company Degussa, and under the  name
Figure PCTCN2019078018-appb-000042
3000 (Guar Hydroxypropyltrimonium Chloride) by the company Aqualon.
The anionic guar gums that may be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acid. The anionic group is preferably a carboxylic acid group. The anionic group may also be in the form of an acid salt, especially a sodium, calcium, lithium or potassium salt.
The anionic guar gums that may be used according to the present invention are preferentially carboxymethyl guar derivatives (carboxymethyl guar or carboxymethyl hydroxypropyl guar) .
Locust bean
Locust bean gum is extracted from the seeds of the locust bean tree Ceratonia siliqua) .
The unmodified locust bean gum that may be used in the present invention is sold, for example, under the name Viscogum TM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name
Figure PCTCN2019078018-appb-000043
LBG by the company Danisco.
The chemically modified locust bean gums that may be used in the present invention may be represented, for example, by the cationic locust beans sold under the name Catinal CLB (locust bean hydroxypropyltrimonium chloride) by the company Toho.
Tara gum
The tara gum that may be used in the context of the present invention is sold, for example, under the name Vidogum SP by the company Unipektin.
Glucomannans (konjac gum)
Glucomannan is a polysaccharide of high molecular weight (500 000<Mglucomannan<2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
The products that may be used according to the present invention are sold, for example, under the names
Figure PCTCN2019078018-appb-000044
and
Figure PCTCN2019078018-appb-000045
by the company Shimizu.
Other polysaccharides
Among the other polysaccharides that may be used according to the present  invention, mention may also be made of chitin (poly-N-acetyl-D-glucosamine, β (1, 4) -2-acetamido-2-deoxy-D-glucose) , chitosan and derivatives (chitosan-β-glycerophosphate, carboxymethylchitin, etc. ) such as those sold by the company France-Chitine; glycosaminoglycans (GAG) such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, and preferably hyaluronic acid; xylans (or arabinoxylans) and derivatives.
Arabinoxylans are polymers of xylose and arabinose, all grouped under the name pentosans. Xylans consist of a main chain of β (1, 4) -linked D-xylose units and on which are found three substituents (Rouau&Thibault, 1987) : acid units, α-L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
According to this variant, the polysaccharide is preferably hyaluronic acid, or a salt thereof.
The at least one hydrophilic gelling agent may be present in an amount ranging for example from 0.001 to 10%by weight, preferably 0.01 to 5%by weight and more preferably from 0.05 to 3%by weight relative to the total weight of the third composition.
Active agents
According to an embodiment of the present invention, the first composition may comprise at least one additional active agent.
According to an embodiment of the present invention, the second composition may comprise at least one additional active agent.
According to an embodiment of the present invention, the third composition may comprise at least one additional active agent.
When the first composition includes the at least one active agent, it may be incorporated into the first composition in particular by means of an alternating electric field. The active agent (s) may be incorporated in particular in the powder state.
Amongst all of the active agents that can be used in the present invention, particular mention can be made of: α- or β-hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, α-hydroxydecanoic acid, α-hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, α-hydroxybutyric acid, α-hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
It is also possible to use anti-acne agents, such as salicylic acid or benzoyl peroxide,  octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned α- and β-hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin F or derivatives thereof, dextrorotary and levorotary sulfur-containing amino acids and derivatives thereof as mentioned above, elastin, N-acetyl D-glucosamine, luteolin, or antioxidants such as green tea or active fractions thereof, glycerin, laponite, caffeine, essential aromatic oils, coloring agents, free-radical scavengers, moisturizers, depigmenting agents, agents for improving the color of the skin such as artificial-tanning agents of the dihydroxyacetone or tyrosin ester type, liporegulators, softeners, anti-wrinkle agents, keratolytic agents, fresheners, deodorants, anesthetics, nourishing agents, and mixtures thereof. It is also possible to use bleaching agents such as kojic acid, ascorbyl phosphates, ascorbyl glucosides, ascorbic acid, and mixtures thereof.
It is also possible to use active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof. It is also possible to use enzymes that have activity on the skin, such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
As other examples of active agents that can be suitable for implementing the present invention there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
The content of the at least one active agent in the first composition and/or in the  third composition may be adjusted as a function of the intended purpose of the kit.
Alkali metal hyaluronic compound
Hyaluronic compound may be also used as an active agent according to the present invention. The hyaluronic compound is preferably an alkali metal hyaluronic compound.
The term "alkali metal hyaluronic compound" in particular means alkali metal salts of hyaluronic acid (hyaluronates) or derivatives thereof. The alkali metal hyaluronic compound is water-soluble.
In the context of the present invention, the term "hyaluronic acid or derivatives thereof" covers in particular the basic unit of hyaluronic acid of formula:
Figure PCTCN2019078018-appb-000046
It is the smallest fraction of hyaluronic acid comprising a disaccharide dimer, namely D-glucuronic acid and N-acetylglucosamine.
The term "hyaluronic acid or derivatives thereof" also comprises, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain via alternating β (1, 4) and β (1, 3) glycosidic linkages, having a molecular weight (Mw) that can range between 380 and 13 000 000 daltons. This molecular weight depends in large part on the source from which the hyaluronic acid is obtained and/or on the preparation methods.
In the natural state, hyaluronic acid is present in pericellular gels, in the base substance of the connective tissues of vertebrate organs such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of the joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.
Thus, the term "hyaluronic acid or derivatives thereof" comprises all the fractions or subunits of hyaluronic acid having a molecular weight in particular within the molecular weight range recalled above.
By way of illustration of the various hyaluronic acid fractions, reference may be made to the document "Hyaluronan fragments: an information-rich system" , R. Stern et al., European Journal of Cell Biology 58 (2006) 699-715, which reviews the listed  biological activities of hyaluronic acid according to its molecular weight.
According to a preferred embodiment of the present invention, the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 50 000 and 5 000 000, in particular between 100 000 and 5 000 000, especially between 400 000 and 5 000 000 Da. In this case, the term used is high-molecular-weight hyaluronic acid.
Alternatively, the hyaluronic acid fractions that may also be suitable for the use covered by the present invention have a molecular weight of between 50 000 and 400 000 Da. In this case, the term used is intermediate-molecular-weight hyaluronic acid.
Alternatively again, the hyaluronic acid fractions that may be suitable for the use covered by the present invention have a molecular weight of less than 50 000 Da. In this case, the term used is low-molecular-weight hyaluronic acid.
Finally, the term "hyaluronic acid or derivatives thereof" also comprises hyaluronic acid esters in particular those in which all or some of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.
More specifically, hyaluronic acid or hyaluronates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates. The polyglycol segment is bonded to hyaluronic acid through the carboxyl group (s) . Typically, hyaluronic acid or hyaluronates react with propylene oxide to form polypropylene glycol hyaluronates, while react with ethylene oxide to form polyethylene glycol hyaluronates.
Further, mention may be made of methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. Such esters have in particular been described in D. Campoccia et al. "Semisynthetic resorbable materials from hyaluronan esterification" , Biomaterials 19 (1998) 2101-2127.
The molecular weights indicated above are also valid for the hyaluronic acid esters.
Adjuvants
In a known manner, the third composition of the present invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour  absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
Needless to say, a person skilled in the art will take care to select this or these optional additional compound (s) , and/or the amount thereof, such that the benefits of the third composition according to the present invention are not, or are not substantially, adversely affected by the envisaged addition.
Galenic form
The third composition according to the present invention may be in various forms, in particular in the form of aqueous solution, dispersion, or emulsion, especially such as a water/oil or oil/water emulsion or multiple emulsions.
An emulsion may have an oily or aqueous continuous phase. Such an emulsion may be, for example, an inverse (W/O) emulsion or a direct (O/W) emulsion, or alternatively a multiple emulsion (W/O/W or O/W/O) .
In the case of emulsions, direct (O/W) emulsions are preferred.
In particular, the third composition according to the present invention may be in the form of an oil-in-water (O/W) emulsion, water-in-oil (W/O) emulsion, or a multiple emulsion, preferably a oil-in-water (O/W) emulsion.
The third composition of the present invention is preferably an aqueous solution.
Kit III
According to the present invention, kit III comprises the third composition comprising a polyvalent metal ion, the fourth composition and the aqueous fifth composition. As the active agent is kept in dry form, the activity thereof is maintained as high as possible.
In an embodiment of the present invention, the third, fourth and fifth compositions are separately placed from each other in kit III. Immediately before use, the fourth composition is added into appropriate amount of the aqueous fifth composition, for dissolving the active agent. With the promotion by the disintegrating agent, the active agent is dissolved very rapidly. Then, the solution of the active agent is applied to the water insoluble substrate of the third composition, e.g., through immersing the substrate in the solution, injecting the solution into the substrate, spraying the solution onto the substrate, or the like.
In another embodiment of the present invention, thanks to the promotion of  dissolution of the active agent by the disintegrating agent, the third and fourth compositions are placed in a same package. Immediately before use, the third and fourth compositions are together added with the aqueous fifth composition. Subsequently, gelatinization between the third and fifth composition, and dissolution of the fourth composition into the fifth composition will concurrently occur. Due to the very rapid dissolution speed of the fourth composition achieved by selecting out the specific disintegrating agent, and optionally the binder, the active agent in the fourth composition, is quickly dissolved into the aqueous phase quite before the completion of gelatinization, such that active agent from the fourth composition is homogeneously distributed in the gel finally formed.
The kit III according to the present invention may comprise 1-10%, preferably 2%-5%by weight of a third composition, 0.5-20%, preferably 1-10%, or 2-5%by weight of a fourth composition, and 70-98.5%, preferably 75-95%by weight of a fifth composition, relative to the total weight of the kit III.
According to a preferred embodiment of the present invention, the kit III presents as a mask comprising:
1) a third composition consisting of a nonwoven fabric (or tissue) comprising from 10%to 100%by weight, preferably from 15%to 50%by weight, of calcium alginate fiber, relative to the total weight of the nonwoven fabric,
2) a fourth composition comprising dry particles of from 20%to 99.9%by weight, preferably from 40%to 95%by weight, especially from 50%to 90%by weight of at least one water soluble/dispersible active agent, and 0.1%to 20%by weight, preferably from 0.2%to 15%by weight, especially from 0.5%to 10%by weight, by weight of at least one disintegrating agent, relative to the total weight of the second composition,
3) a fifth composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of sodium alginate, and from 0.1%to 2%by weight, preferably from 0.2%to 1%by weight, of sodium citrate, relative to the total weight of the third composition,
wherein the mask comprises 1-10%, preferably 2-5%by weight of the third composition, 0.5-20%, preferably 1-10%, or 2-5%by weight of the fourth composition, and 70-98.5%, preferably 75-95%by weight of the fifth composition, relative to the total  weight of the mask.
Method and use
The first to fifth compositions according to the present invention can be generally prepared according to the general knowledge of a person skilled in the art. Nevertheless, it is to be understood that a person skilled in the art can choose its method of preparation, on the basis of his/her general knowledge, taking into account the nature of the constituents used, for example, their solubility in the vehicle, and the application envisaged for the compositions or the kit.
According to an embodiment, the kit I, II and/or III according to the present invention can be used for conditioning keratin materials, especially the face. This use may manifest itself as a process for conditioning keratin materials, especially the face, comprising the steps of compounding the first composition and the second composition, and optionally the third composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture as a mask.
According to an embodiment, the kit I, II and/or III according to the present invention can be used for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on. This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the third composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture as a mask or stuffing.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the present invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contain certain errors necessarily resulting from the standard deviation found in their respective measurements. The following examples are intended to illustrate the present invention without limiting the scope as a result.
EXAMPLES
The ingredient amounts/concentrations in the compositions/formulas described  below are expressed in %by weight, relative to the total weight of each composition/formula.
I. Preparation
The invention formulas A and B, and comparative formula A were prepared, as the second composition.
Table 1
Figure PCTCN2019078018-appb-000047
The invention formulas C and D were prepared, as the third composition.
Table 2
Figure PCTCN2019078018-appb-000048
In table 1, comparative A doesn’t contain TRISODIUM CITRATE as compared with the invention formula A.
Protocol of preparation using the second composition in table 1: Putting all the ingredients into beaker, heated to 60℃ and homogenized until uniform, cooled down to room temperature. As the first composition, a nonwoven fabric made of solely (100% by weight) of calcium alginate fiber sold by the Sanjiang company under the name M762R-40CN was used.
Protocol of preparation using the third composition in table 2: Putting all the ingredients into beaker, heated to 60℃ and homogenized until uniform, cooled down to room temperature. As the first compositions, for invention formula C, a nonwoven fabric made of 20%by weight of calcium alginate fiber and 80%by weight of tencel fiber was used; for the invention formula D, a nonwoven fabric made of 100%tencel fiber and treated with calcium stearate was used.
Example E
Tissue: 1.5 gram, 20%by weight calcium alginate comprising 5%by weight of ferulic acid+80%tencel fiber;
Protocol of preparation using the first composition in table 1: adding 30g of water in the first composition, stirring until completely dissolved, then mixing with tissue.
II. Evaluation of the invention and comparative masks
The present invention and comparative masks were evaluated using the following protocols.
Method for texture transformation evaluation
Five panelists evaluated the gelling area on tissue by visual way and graded from poor to excellent which was classified in the following 4 categories based on the average of the grade: “excellent” (>50%) , “good” (30-50%) , “fair” (10-30%) , or “poor” (<10%) .
Method for fresh feel evaluation
Five panelists evaluated the degree of greasiness of skin by the tactile way when slight moving finger pulp on the face.
Evaluation process: Apply the mask on face for 15 minutes and then take off and massage the skin. Perceive the greasiness of skin by moving finger pulp on the face. Then each panelist gave the score from 0 to 15. The less greasiness, the high score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) ,  “poor” (0-4) .
Method for skin adhesion evaluation
Five panelists evaluated the degree of mask adhered on face, the level of bubbles around eye, nose and mouth by visual way with a mirror under the standardized light.
Evaluation process: Apply the mask on face, and observe the quantity of bubbles around eye, nose and mouth. Then each panelist gave the score from 0 to 15. The less bubbles, the high score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
Method for hydration effect evaluation
Five panelists evaluated the hydration effect of the masks, in view of the plumpy, fine line improvement and soft skin that provided by the formulas.
Evaluation process: Apply the mask on face for 15 minutes and then take off and massage the skin. Observe the degree of lines on forehead and nasolabial folds, touch the cheek by index finger and middle figer and perceive the skin softness by tactile way, and observe the degree of fine lines on the cheek. Each panelist gave the score from 0 to 15. The more plumpy skin, the high score was given.
Evaluation Index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
Method for moisture delivery capacity evaluation
Five panelists evaluated the quantity of juice left on skin after take-off the mask by visual way with a mirror under the standardized light.
Evaluation process: Apply the mask on face for 15 minutes and then take off. Observe the quantity of juice left on skin by visual way. Then each panelist gave the score from 0 to 15. The more juice left on skin, the higher score was given.
Evaluation index: We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
The results obtained are detailed in the table hereunder:
  Invention A Invention B Comparative A
Texture transformation Good Excellent poor
Skin adhesion Excellent Excellent fair
Fresh feel Excellent Fair good
Hydration effect good Excellent fair
Moisture delivery capacity excellent Fair poor
III. Conclusion
The mask of the present invention is superior in terms of beneficial properties, e.g. texture transformation, hydration effect and moisture delivery capacity, over the comparative one.
The term "comprising" (and its grammatical variations) as used herein is used in the inclusive sense of "having" or "including" and not in the exclusive sense of "consisting only of" . The terms "a" and "the" as used herein are understood to encompass the plural as well as the singular.
The foregoing description illustrates and describes the present disclosure. Additionally, the disclosure shows and describes only the preferred embodiments of the disclosure, but, as mentioned above, it is to be understood that it is capable of changes or modifications within the scope of the concept as expressed herein, commensurate with the above teachings and/or skill or knowledge of the relevant art. The described hereinabove are further intended to explain best modes known of practicing the disclosure and to enable others skilled in the art to utilize the disclosure in such, or other embodiments and with the various modifications required by the particular applications or uses disclosed herein. Accordingly, the description is not intended to limit the disclosure to the form disclosed herein. Also it is intended that the appended claims be construed to include alternative embodiments.
All publications, patents and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication, patent or patent application were specifically and individually indicates to be incorporated by reference. In this case of inconsistencies, the present disclosure will prevail.

Claims (29)

  1. A kit I, comprising:
    1) a first composition in dry form, comprising a water insoluble substrate comprising at least one water insoluble salt of polyvalent metal and optionally, a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and
    2) a second composition comprising at least one aqueous phase, and
    a) at least one water soluble chelating agent of the polyvalent metal ion, and
    b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion;
    wherein the first composition and the second composition are separately placed from one another; and
    wherein the water soluble/dispersible active agent is distributed uniformly in the substrate.
  2. Kit I according to claim 1, wherein the gelatinizing agent is specifically selected to have an ability of combining with the polyvalent metal ions lower than that of the chelating agent;
  3. Kit I according to claim 1 or 2, wherein the at least one water insoluble salt of polyvalent metal is a water insoluble alginate chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a mixture thereof, preferably calcium alginate.
  4. Kit I according to anyone of the preceding claims, wherein the first composition is a woven or nonwoven fabric made of a fiber of the at least one water insoluble alginate solely or together with one or more other fibers chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers, or a mixture thereof.
  5. Kit I according to anyone of the preceding claims, wherein the at least one water insoluble salt of polyvalent metal is present in the first composition from 20%to 100%by weight, preferably from 20%to 50%by weight, relative to the total weight of the first composition.
  6. Kit I according to anyone of the preceding claims, wherein the active agent is selected from the group consisting of retinoids, vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B group (e.g., vitamin B5 (panthenol) , vitamin B3 (niacinamide) , vitamin B1 and vitamin B2) , vitamin D, vitamin K, nicotinic acid, folic acid, pantothenic acid, ferulic acid, ascorbic acid 2-glucoside, dipalmiroyl hydroxyproline, or a derivative thereof, such as a salt or ester thereof.
  7. The kit I according to any one of the preceding claims, wherein the water soluble/dispersible active agent is selected from the group consisting of retinoic acid, retinol (vitamin A) and its esters, such as, retinyl propionate, and retinyl acetate, or retinyl palmitate.
  8. The kit I according to any one of the preceding claims, wherein the water soluble/dispersible active agent is retinol or ferulic acid.
  9. Kit I according to anyone of the preceding claims, wherein the at least one water soluble chelating agent is chosen from sodium citrate, disodium EDTA, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, potassium phytate, and mixtures thereof.
  10. Kit I according to anyone of the preceding claims, wherein the at least one water soluble chelating agent of the polyvalent metal ion is present in the second composition from 0.1%to 1%by weight, preferably from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
  11. Kit I according to anyone of the preceding claims, wherein the gelatinizing agent is chosen from alkali metal alginates, alkali metal salts of alginic acid derivative, or a mixture thereof, preferably from sodium alginate, potassium alginate, lithium alginate, sodium polyethylene glycol alginates, potassium polyethylene glycol alginates, lithium polyethylene glycol alginates, or a mixture thereof.
  12. Kit I according to anyone of the preceding claims, wherein the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
  13. Kit I according to anyone of the preceding claims, wherein the at least one aqueous phase is present in the second composition from 10%to 99%by weight,  preferably from 50%to 99%by weight, relative to the total weight of the second composition.
  14. Kit I according to anyone of the preceding claims, wherein the weight ratio of the first composition to the second composition ranges from 1: 3 to 1: 20, preferably from 1:8 to 1: 1.
  15. A kit II comprising:
    1) a third composition comprising at least one water insoluble substrate; and
    2) a fourth composition in dry form, comprising a water soluble/dispersible active agent which is unstable in its solvated/dispersed state, and a disintegrating agent.
  16. The kit II according to claim 15, wherein the water insoluble substrate comprises the water insoluble alginate fiber, especially calcium alginate fiber, in an amount ranging from 10%to 100%by weight, especially from 15%to 50%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  17. The kit II according to any one of claims 15-16, wherein the weight ratio of the third composition to the fourth composition ranges from 10: 1 to 1: 10, or from 2: 1 to 1: 2 
  18. The kit II according to any one of claims 15-17, wherein the water soluble/dispersible active agent is selected from the group consisting of retinoids, vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B group (e.g., vitamin B5 (panthenol) , vitamin B3 (niacinamide) , vitamin B1 and vitamin B2) , vitamin D, vitamin K, nicotinic acid, folic acid, pantothenic acid, ferulic acid, ascorbic acid 2-glucoside, dipalmiroyl hydroxyproline, or a derivative thereof, such as a salt or ester thereof.
  19. The kit I according to any one of claims 15-18, wherein the water soluble/dispersible active agent is selected from the group consisting of retinoic acid, retinol (vitamin A) and its esters, such as, retinyl propionate, and retinyl acetate, or retinyl palmitate.
  20. The kit II according to any one of claims 15-18, wherein the water soluble/dispersible active agent is retinol or ferulic acid.
  21. The kit II according to any one of claims 15-20, wherein the disintegrating agent is selected from the group consisting of monosaccharide, preferably glucose and fructose; disaccharide, preferably sucrose; and saccharide alcohol, preferably sorbitol and mannitol.
  22. The kit II according to any one of claims 15-21, wherein the weight ratio of the  disintegrating agent to the active agent in the fourth composition ranges from 1: 100 to 1: 4, preferably from 1: 50 to 1: 5, or preferably from 1: 20 to 1: 10.
  23. The kit II according to any one of claims 15-22, wherein the disintegrating agent and the active agent are together formed into an integrated solid state, e.g., particles, including granules, spheres, balls, bars, strips or the like.
  24. The kit II according to any one of claims 15-23, wherein a binder additional to and different from the disintegrating agent is added to form the integrated solid state wherein the binder is selected from the group consisting of polyvinyl alcohol, sodium alginate, xanthan and agar.
  25. The kit II according to any one of claims 15-24, where the third composition comprises a polyvalent metal ion; and
    the kit II further comprises a fifth composition comprising:
    a) . at least one aqueous phase, and
    b) . at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion;
    wherein the gelatinizing agent is chosen from alkali metal alginates, alkali metal salts of alginic acid derivative, or a mixture thereof, preferably from sodium alginate, potassium alginate, lithium alginate, sodium polyethylene glycol alginates, potassium polyethylene glycol alginates, lithium polyethylene glycol alginates, or a mixture thereof.
  26. The kit II according to claim 25, wherein the at least one water soluble gelatinizing agent is present in the fifth composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the fifth composition.
  27. The kit II according to any one of claims 25-26, wherein the fifth composition further comprises:
    c) . at least one water soluble chelating agent of the polyvalent metal ion;
    wherein the at least one water soluble chelating agent is chosen from sodium citrate, disodium EDTA, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, potassium phytate, and mixtures thereof.
  28. The kit II according to any one of claims 25-27, wherein the at least one water soluble chelating agent of the polyvalent metal ion is present in the fifth composition from 0.1%to 1%by weight, preferably from 0.2%to 0.4%by weight, relative to the total  weight of the fifth composition.
  29. The kit II according to any one of claims 25-28, wherein the at least one aqueous phase is present in the fifth composition from 10%to 99%by weight, preferably from 50%to 99%by weight, relative to the total weight of the fifth composition.
PCT/CN2019/078018 2018-06-28 2019-03-13 Kit for caring for the skin WO2020001069A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201980043523.5A CN112334124A (en) 2018-06-28 2019-03-13 Kit for caring for skin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/093258 2018-06-28
PCT/CN2018/093258 WO2020000290A1 (en) 2018-06-28 2018-06-28 Composition for caring for skin and a kit thereof
PCT/CN2018/113992 WO2020093206A1 (en) 2018-11-05 2018-11-05 Kit for caring for the skin
CNPCT/CN2018/113992 2018-11-05

Publications (1)

Publication Number Publication Date
WO2020001069A1 true WO2020001069A1 (en) 2020-01-02

Family

ID=68985322

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/078018 WO2020001069A1 (en) 2018-06-28 2019-03-13 Kit for caring for the skin

Country Status (2)

Country Link
CN (1) CN112334124A (en)
WO (1) WO2020001069A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3108506A1 (en) * 2020-03-30 2021-10-01 L'oreal COMPOSITION IN TWO CARE PARTS OF KERATIN MATERIALS
FR3110850A1 (en) * 2020-04-30 2021-12-03 L'oreal SKIN CARE KIT
FR3122330A1 (en) * 2021-04-29 2022-11-04 L'oreal SKIN CARE KIT
FR3126303A1 (en) * 2021-08-25 2023-03-03 L'oreal Mask for the care of keratinous materials
FR3133016A1 (en) 2022-02-25 2023-09-01 L'oreal care composition for keratinous materials and mask containing the same
WO2023184315A1 (en) * 2022-03-31 2023-10-05 L'oreal Kit for caring for keratin materials
FR3136371A1 (en) * 2022-05-06 2023-12-15 L'oreal Care composition for keratin materials and mask containing the same
FR3139006A1 (en) 2022-08-31 2024-03-01 L'oreal Composition for the care of keratinous materials and mask containing it
FR3140265A1 (en) 2022-09-30 2024-04-05 L'oreal Care composition of keratinous materials and mask containing it
FR3142900A1 (en) 2022-11-08 2024-06-14 L'oreal KERATINOUS MATERIAL CARE COMPOSITION AND MASK CONTAINING IT

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022205059A1 (en) * 2021-03-31 2022-10-06 L'oreal Compositions for caring for skin and a package for containing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361700A (en) * 2007-08-08 2009-02-11 秦益民 Face mask material containing alginic acid fiber, preparation method and use thereof
CN104803082A (en) * 2014-01-24 2015-07-29 李和伟 Novel three-chamber facial mask packing bag including freeze-drying endowed preparation and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1174982A (en) * 1980-07-31 1984-09-25 Margaret Lindenthal Face mask using alginates
US20040219124A1 (en) * 2003-05-01 2004-11-04 Gupta Shyam K. Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
JP2015067585A (en) * 2013-09-30 2015-04-13 株式会社マンダム Skin cosmetic kit

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361700A (en) * 2007-08-08 2009-02-11 秦益民 Face mask material containing alginic acid fiber, preparation method and use thereof
CN104803082A (en) * 2014-01-24 2015-07-29 李和伟 Novel three-chamber facial mask packing bag including freeze-drying endowed preparation and preparation method thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3108506A1 (en) * 2020-03-30 2021-10-01 L'oreal COMPOSITION IN TWO CARE PARTS OF KERATIN MATERIALS
FR3110850A1 (en) * 2020-04-30 2021-12-03 L'oreal SKIN CARE KIT
FR3122330A1 (en) * 2021-04-29 2022-11-04 L'oreal SKIN CARE KIT
FR3126303A1 (en) * 2021-08-25 2023-03-03 L'oreal Mask for the care of keratinous materials
FR3133016A1 (en) 2022-02-25 2023-09-01 L'oreal care composition for keratinous materials and mask containing the same
WO2023184315A1 (en) * 2022-03-31 2023-10-05 L'oreal Kit for caring for keratin materials
FR3136371A1 (en) * 2022-05-06 2023-12-15 L'oreal Care composition for keratin materials and mask containing the same
FR3139006A1 (en) 2022-08-31 2024-03-01 L'oreal Composition for the care of keratinous materials and mask containing it
WO2024045049A1 (en) * 2022-08-31 2024-03-07 L'oreal Composition for caring for keratin materials and mask containing the same
FR3140265A1 (en) 2022-09-30 2024-04-05 L'oreal Care composition of keratinous materials and mask containing it
FR3142900A1 (en) 2022-11-08 2024-06-14 L'oreal KERATINOUS MATERIAL CARE COMPOSITION AND MASK CONTAINING IT

Also Published As

Publication number Publication date
CN112334124A (en) 2021-02-05

Similar Documents

Publication Publication Date Title
WO2020001069A1 (en) Kit for caring for the skin
WO2019047954A1 (en) Kit for caring for the skin
US11304881B2 (en) Composition based on an aqueous phase containing a dispersion of an anhydrous composite material
CN115192473B (en) Kit for caring skin
WO2020093206A1 (en) Kit for caring for the skin
CN113194906B (en) Kit for skin care
US20200138680A1 (en) Gel-type cosmetic composition
WO2020181405A1 (en) Kit for caring for the skin
WO2020133308A1 (en) Kit for caring for the skin
WO2019185915A1 (en) Foaming aqueous gel comprising a modified starch and a non-starchy polysaccharide
WO2021217560A1 (en) Kit for caring for the skin
WO2020258219A1 (en) Kit for caring for the skin
Shoaib et al. Applications of polysaccharides in controlled release drug delivery system
EP2945599B1 (en) Cosmetic composition comprising a specific polysaccharide, an anionic fixing polymer and a liquid monoalcohol or polyol, and cosmetic treatment method employing it
CN114585348A (en) Composition for caring skin
WO2022123016A1 (en) Cosmetic substrate of natural origin
WO2021245081A1 (en) Composition comprising at least three types of polysaccharides, at least one pasty compound of plant origin and water
WO2019185913A1 (en) Anhydrous exfoliating composition comprising c3-c10 polyols and polysaccharides
JP2024085649A (en) Composition comprising combination of electrolyte and polysaccharide
WO2024128168A1 (en) Composition comprising electrolyte and combination of polysaccharides
WO2023184295A1 (en) Composition for caring for keratin material
FR3023476A1 (en) AQUEOUS SOLID COMPOSITION CONTAINING A FATTY ACID SALT, A POLYOL AND A HYDROPHILIC GELIFIER
WO2022226872A1 (en) Kit for caring for the skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19826900

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19826900

Country of ref document: EP

Kind code of ref document: A1